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1.1. The heterogeneity problem of categorical psychiatric nosology 
Within more than a century, psychologists and psychiatrists have developed and revised 
the psychiatric nosology of the major psychiatric disorders [i.e. major depressive disorder 
(MDD), schizophrenia (SZ), bipolar disorder (BD), schizoaffective disorder (SZA)] 
previously established by Emil Kraepelin (Kraepelin, 1919). The Diagnostic and 
Statistical Manual of Mental Disorders (DSM) (American Psychiatric Association, 1994) 
as well as the International Classification of Diseases (ICD) (World Health Organization, 
1993) constitute the major classification systems of mental disorders. While the US 
American DSM is organized in a five-part axial system diagnosing only mental health 
disorders, the ICD is a broader classification system covering general as well as mental 
health. Both are used as categorical classifications systems classifying psychiatric 
disorders based on a set of specific and standardized criteria assuming more or less 
strict boundaries between individuals with and without disorder, but also among different 
diagnostic categories (Tabb, 2015). Hence, the DSM and ICD classification systems are 
based on the following principle: in order to be given a diagnosis X, a patient must 
present a symptom A as well as other symptoms B,C, and D over a certain period of time 
E, and the symptoms F and G should not be present. Both the DSM and ICD are highly 
convergent and it is possible to adapt diagnoses (Tyrer, 2014). The DSM and ICD have 
been used to classify psychiatric disorders in clinical practice as well as research over 
the past decades, providing standardized precise criteria that also permit comorbidities. 
The use of the DSM and ICD allows diagnostic agreement and communication across 
multiple nations (Helzer et al., 2006). However, in light of the failure to validate these 
categories on a neurobiological level, there is increasing criticism of their use (Caspi & 
Moffitt, 2018; Conway et al., 2019; Hengartner & Lehmann, 2017; Krueger & Bezdjian, 
2009) which can be summarized into two major aspects: (1) the overlap across mental 
disorders and (2) the categorical comparison of disorders and healthy control groups 
(Feczko et al., 2019).  
The overlap across mental disorders (1) has been scientifically demonstrated on several 
levels. These include shared phenomenology across diagnostic categories, as there is 
evidence for elevated psychotic symptoms in MDD patients (Johns et al., 2004; 
Varghese et al., 2011). Vice versa, depressive symptoms in SZ (Upthegrove et al., 2016) 
have been reported to be an important factor for completed suicide (Dutta et al., 2011) 
and long term consequence for functional recovery (Conley et al., 2007). Moreover, 
formal thought disorder (FTD) has been reported across disorders, as well (Kircher et 
al., 2014, 2018). Evidence for a shared neurobiology is given by familial and molecular 
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genetic risk studies (Anttila et al., 2018) showing common variant risk across mental 
disorders. In addition, there is evidence for shared environmental factors [i.e. pregnancy 
risk factors, perinatal risk factors, childhood environment, drug use in adolescence] being 
associated with the major psychiatric disorders (Uher & Zwicker, 2017). Additionally, a 
meta-analysis of blood cytokine network alterations in the major psychiatric disorders 
showed that the levels of cytokines were commonly increased across acutely ill patients 
when compared to a healthy control group (Goldsmith et al., 2016). On a brain structural 
level, the comparison of SZ, BD, and MDD patients to a healthy control group revealed 
87.9% of shared gray matter volume (GMV) decreases across disorders. These common 
anatomical structures were located in paralimbic and heteromodal regions including the 
temporal pole, orbitofrontal cortex, insula, hippocampal, cingulate and angular gyri 
(Chang et al., 2018). Common altered white matter brain structures across SZ and BD 
patients were reported in callosal, limbic-paralimbic-heteromodal, cortico-cortical, 
thalamocortical and cerebellar tracts, though this overlap was not reported for MDD 
patients (Chang et al., 2018). Further evidence for shared brain structural alterations 
across disorders is given by a meta-analysis pooling results from single case-control 
studies showing GMV loss across disorders converged in the dorsal anterior cingulate 
and bilateral insulae (Goodkind et al., 2015). Together, previous studies investigating the 
neurobiological overlapping of the major psychiatric disorders either focused on the 
comparison of one disorder to a healthy control group and were then pooled in meta-
analyses, or on the comparison of multiple disorders to a healthy control group leading 
over to the second limitation. Using categorical approaches (2) comparing populations 
leads to two problematic aspects. First, categorical approaches are based on the 
assumption that a given disorder constitutes a homogeneous construct with distinct 
boundaries between categories (Feczko et al., 2019; Tabb, 2015). However, these 
boundaries often appear to be vague and research on single psychiatric categories failed 
to determine discrete taxa (Hengartner & Lehmann, 2017). Second, categorical 
approaches merely acknowledge characteristics above and below the categorical 
thresholds (Helzer et al., 2006), using not otherwise specified diagnoses that do not fit 
into official diagnoses. Using cut-off criteria to distinguish healthy controls from patients 
limits detecting sub-clinical symptoms and distorts findings from case-control studies. On 
a neurobiological level, there is already evidence for brain structural variations across 
the sub-clinical depression/anxiety spectra (Besteher et al., 2017, 2020) and sub-clinical 
psychotic like experiences (Meller et al., 2020) in the healthy population. Further 
importance for dimensional approaches is given by a meta-analysis reporting 15% 
greater reliability and a 68% chance of better test-retest reliabilities of dimensional 
assessments when compared to categorical measures (Markon et al., 2011). 
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1.2. Dimensional psychopathology 
Dimensional methods investigating descriptive psychopathology rather than categorical 
approaches can overcome the limitations, particularly for research purposes, as 
described above (Feczko et al., 2019; Helzer et al., 2006; Hengartner & Lehmann, 2017; 
Reininghaus et al., 2016). Both supervised and unsupervised approaches are useful 
methods acknowledging this endeavor. While unsupervised approaches are based on 
the character of the data without prior assumptions, supervised approaches built on prior 
knowledge (Feczko et al., 2019). Moreover, the importance of complex dimensional 
modelling is highlighted by studies investigating predictors for disorder onset showing a 
combination of predictors including clinical, personality, and brain structural measures 
(Klein et al., 2013; Toenders et al., 2021).  
Besides the need for complex models predicting disorders, there is also a demand for 
dimensional models to better understand the psychopathology after disorder onset. 
Hereof, several attempts have been made to delineate psychopathological dimensions 
focusing on continuously distributed phenomena (Conway et al., 2019). Previously, 
factor analyses have been reported to be a useful method to investigate dimensional 
psychopathology (Allsopp et al., 2019; Reininghaus et al., 2016). 
Explorative and confirmatory factor analyses of psychopathological symptoms within 
single clinically defined categories revealed three to eleven factors in psychotic disorders 
(Emsley et al., 2003; Liddle, 1987; Peralta et al., 1997; Peralta & Cuesta, 1999; Rapado-
Castro et al., 2010), one to four factors in MDD (Li et al., 2014), and five to seven factors 
in BD (Baek et al., 2018; Hanwella & de Silva, 2011; Harvey et al., 2008; Sato et al., 
2002). Transdiagnostic investigations on the factorial structure across diagnosis [i.e. 
MDD, BD, SZ] indicated three (Romney & Candido, 2001) to five (van Dorn et al., 2016) 
factors. More recently, hierarchically structured models have been reported to better 
represent factorial dimensions (Anderson et al., 2018; Reininghaus et al., 2013, 2016, 
2019). Using three psychopathological scales, Reininghaus et al. showed that symptom 
dimensions across psychotic BD and SZ are best described by a model comprising one 
general psychosis domain, two dimensions of affective and non-affective psychosis, and 
five additional factors (Reininghaus et al., 2019). Usually, these factor models comprised 
paranoid-hallucinatory, depressive, negative, and manic dimensions.  
In light of hierarchical structured dimensional models, the hierarchical taxonomy of 
psychopathology (HiTOP) (Kotov et al., 2017) has been developed. This unsupervised 
model assumes psychopathology to be hierarchically structured with symptoms on the 
first level which are summarized into syndromes/disorders on the second level. The latter 
are nested within factors on the third level and are then pooled with broad spectra on the 
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fourth level. Lastly, on the fifth level, broader spectra are pooled in one superspectrum 
(Kotov et al., 2017, 2018).  
Models such as HiTOP might be a first starting point for a new taxonomy or ultimately 
nosology in psychiatric research. In contrast to categorical approaches, transdiagnostic 
dimensional investigations account for neurobiological overlapping across disorders and 
can in a next step be used to investigate the neurobiology of the major psychiatric 
disorders on a dimensional, data driven level.  
 
1.3. Neural correlates of dimensional psychopathology 
Brain structural as well as functional magnetic resonance imaging measures are crucial 
methods which aid the prediction as well as the pathophysiological understanding of 
mental disorders. Recently, brain structural measures were used to predict the onset of 
depression reporting the surface area of the supramarginal gyrus to be a contributor to 
a complex predictive model (Toenders et al., 2021). Predicting a conversion to a 
diagnosis of SZ from a high-risk state showed a 94% accuracy when a complex model 
including psychopathology, neuro-cognition and brain structure was combined to a single 
learning algorithm (Zarogianni et al., 2017).  
Besides the prediction of disorder onset, brain structural measures were also used to 
determine sub-groups or prototypes across disorders. In this regard, multimodal machine 
learning was used to identify prototypes of depression and psychosis showing that 87% 
of recent onset depression and psychosis patients could be accurately assigned to the 
primary diagnostic group based on GMV. However, when including psychotic patients 
with affective comorbidities, only 37% could be assigned accurately pointing to a lack of 
points of rarity across disorders, specifically in patients with complex comorbidities 
(Lalousis et al., 2021). Moreover, while the separation of SZ and MDD based on 
neuroanatomical data and machine learning algorithms is possible, specifically in 
patients with disorder onset at younger ages, neuroanatomical signatures fail to separate 
affective and psychotic disorders (Koutsouleris et al., 2015).  
Beyond the prediction and separation of mental disorders based on neuro-anatomical 
features, it is also important to investigate transdiagnostic neural substrates of 
psychopathology gaining a more precise understanding of the pathophysiology 
underlying mental disorders. Results of such studies can in a next step be used to inform 
complex models predicting onset and disorder course. Studies investigating such 
substrates were mostly performed in diagnostic categories that specifically exhibit 
symptoms of such dimensional factors. For each symptom complex results are 
heterogeneous as some studies found evidence for correlations between 
psychopathology and GMV while others did not.  
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Summarizing studies on positive symptoms in SZ patients, a GMV network of temporal 
and frontal regions was negatively correlated with positive symptoms [i.e. delusions and 
hallucinations] (Mennigen et al., 2019; Padmanabhan et al., 2015; Palaniyappan et al., 
2012). Moreover, one study suggested associations of both positives and depressive 
symptoms to be inversely correlated with the prefrontal cortex volume indicating that 
depressive symptoms might be involved in hearing voices (Siddi et al., 2019). Even 
though, previous research on the associations of GMV and positive symptoms revealed 
a set of core regions being implicated in positives symptoms, results remain 
heterogeneous as some other studies reported no associations (Gupta et al., 2015).   
GMV correlates of FTD include volume reductions in the language network comprising 
the left frontal operculum, bilateral inferior frontal gyri, bilateral superior temporal gyri, 
and the left angular gyrus (Cavelti, et al., 2018; Kircher et al., 2018). Again, while there 
seems to be consensus about core regions being implicated in FTD, results continue to 
be mixed and there is a complete lack of transdiagnostic dimensional studies untangling 
brain structural correlates of FTD.  
Negative symptoms in SZ patients have been associated with a number of GMV 
reductions. These included the orbitofrontal cortex, the anterior cingulate cortex, fusiform 
gyrus, thalamus, caudate, and the amygdala (İnce & Üçok, 2018; Walton et al., 2018). 
However, results on associations of negative symptoms and GMV are even more 
heterogonous than for positive or FTD symptoms as several studies reported no GMV 
associations (Banaj et al., 2018; Collin et al., 2012). In contrast to GMV, Padmanabhan 
et al. reported an inverse correlation of negative symptoms with a right frontal surface 
area including the right pars orbitalis, superior frontal and precentral surface 
(Padmanabhan et al., 2015), indicating other brain structural measures than GMV that 
might be implicated in negative symptoms.  
Depressive symptoms in MDD patients have been associated with GMV reductions in 
the right orbitofrontal cortex, left hippocampal gyrus, and right dorsolateral prefrontal 
cortex (Vasic et al., 2008). However, there is evidence for structural alterations being 
associated with chronicity and cumulative severity rather than depressive 
symptomatology (Abe et al., 2010; Grieve et al., 2013; Zaremba et al., 2018a, 2018b).  
To sum up, brain structural measures are a useful framework for both prediction and 
understanding mental disorders. A number of studies on the associations of 
psychopathology factors and GMV has been performed resulting in ambiguous findings. 
Specifically, the associations of transdiagnostic psychopathological factors and GMV 
across disorders remain largely elusive.  
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1.4. Neuro-cognitive correlates of dimensional psychopathology 
Neuro-cognitive deficits across the major psychiatric disorders have become of great 
interest in both research and therapy. Neuro-cognition has been reported to be a 
predictor of conversion to SZ from at-risk states (Seidman et al., 2010) and functional 
impairment in SZ patients (Harvey et al., 2012). While some studies indicated poorer 
cognitive performance in psychotic disorders [i.e. SZ] than in affective disorders [i.e. 
MDD and BD] (Barch, 2009; Huang et al., 2020; Lee et al., 2018), there is increasing 
evidence for a great overlap of neuro-cognitive functioning across disorders (Ancín et 
al., 2013; Huang et al., 2020), as well. However, it remains unclear whether the 
impairment of cognitive functioning can be explained by the diagnosis itself or rather by 
multidetermined psychopathological factors (Millan et al., 2012; van Os & Reininghaus, 
2016).  
Studies investigating the association of dimensional psychopathology and neuro-
cognition revealed moderate correlations of negative symptoms (Bozikas, Kosmidis, 
Kioperlidou, & Karavatos, 2004; de Gracia Dominguez et al., 2009; Huang et al., 2016) 
and FTD (de Gracia Dominguez et al., 2009) with neuro-cognition while correlations with 
positive (de Gracia Dominguez et al., 2009) and affective, depressive symptoms (Zhu et 
al., 2019) were significantly weaker. Though, few studies are available investigating the 
association of transdiagnostic psychopathology factors and neuro-cognition across 
disorders. In line with the results reported above, a recent transdiagnostic study reported 
correlations of negative and disorganized [i.e. FTD] symptoms with a broad range of 
cognitive functioning including verbal fluency, visuo-spatial working memory, and 
processing speed but no correlations of positive and depressive symptoms and neuro-
cognition (Zhu et al., 2019). Importantly, correlations of neuro-cognition and 
psychopathology appear to be modulated by the severity and the course of illness. 
Neuro-cognitive impairment has been stated during acute episodes, while these findings 
were not present in remitted patients (Bowie et al., 2018; Zaremba et al., 2019). Besides 
the current state of patients, other clinical variables [i.e. age of onset, illness severity] 
have been reported to influence the neuro-cognitive impairment. For instance, one study 
suggested SZ patients with youth-onset had more severe cognitive deficits, while 
patients with late-onset retained cognitive functioning (Barder et al., 2013). Based on 
these findings, a more complex evaluation integrating the current state and illness course 





1.5. Objectives and hypotheses 
The studies of this dissertation aimed to examine the neurobiology of the major 
psychiatric disorders using a dimensional investigation of both phenotype as well as 
neuroanatomy and neuro-cognition.  
In particular, the first objective was to establish a cross-validated factor model across 
disorders comprising a comprehensive set of symptoms including depressive, positive, 
negative, and anxiety symptomatology. Hereof, this dissertation hypothesized (H1) 
psychopathology being clustered into three to five factors and these factors being 
present in all diagnoses tested. Beyond, (H2) the extracted factors of first order would 
load on more global factors of second order confirming the better fit of hierarchically 
structured models.  
The second objective was to link this model to neurobiological determinants [i.e. brain 
structure and neuro-cognition]. Referring to brain structural correlates of dimensional 
psychopathology factors, it was hypothesized (H3) that local GMV associations 
previously reported in single DSM-IV disorders cut across affective and psychotic 
disorders. Further, these associations were hypothesized to be independent of 
diagnostic categories (H4).  
Based on previous studies on the associations of psychopathological factors and neuro-
cognition, correlations were expected to be state-dependent (H5). 
Subsequently, FTD as core psychiatric symptom was mapped for phenotype dimensions 
as well as neuroanatomical signatures across disorders. Hereby, a factor model 
including one negative domain and further positive factors was assumed. Additionally, 
previous gray and white matter alterations reported in SZ only, were expected to be 












2. AGGREGATION OF STUDY RESULTS 
2.1. STUDY I: Factor analyses of multidimensional symptoms in a large group 
of patients with major depressive disorder, bipolar disorder, 
schizoaffective disorder and schizophrenia 
 
Reference: Stein F, Lemmer G, Schmitt S, Brosch K, Meller T, Fischer E, Kraus C, Lenhard L, 
Köhnlein B, Murata H, Bäcker A, Müller M, Franz M, Förster K, Meinert S, Enneking V, Koch K, 
Grotegerd D, Nagels A, Nenadić I, Dannlowski U, Kircher T, Krug A. Factor analyses of 
multidimensional symptoms in a large group of patients with major depressive disorder, bipolar 
disorder, schizoaffective disorder and schizophrenia. Schizophr Res. 2020 Apr; 218:38-47. doi: 
10.1016/j.schres.2020.03.011. (IF 4.6) 
 
Although the dichotomization of „dementia praecox“ and „manic-depressive illness“ by 
Kraepelin (Kraepelin, 1919) has been confirmed to be useful from a clinical perspective, 
more than a century of research failed to define "points of rarity" between affective as 
well as psychotic disorders. In contrast, studies have shown evidence for a cross-
disorder overlap in phenomenology (Johns et al., 2004; Rosen et al., 2012; Varghese et 
al., 2011), molecular genetic risk (Goldsmith et al., 2016;Lee et al., 2019), but also in 
environmental risk (Uher & Zwicker, 2017). Dimensional approaches rather than 
categorical comparisons of one disorder and a healthy control group, can serve as an 
important addition to traditional approaches overcoming a scientific deadlock which has 
one origin in a misguided reification of DSM diagnostic categories. Dimensional factor 
analyses can be a useful statistical method to provide significant progress for our 
understanding of a shared phenomenology. However, previous studies on factorial 
dimensions were limited to the investigation of only two diagnostic categories, not 
performing transdiagnostic analyses or only assessing a limited number of symptoms. 
Only few studies investigated the dimensional factorial structure across disorders 
showing three to five factors (Romney & Candido, 2001; Serretti et al., 2001; Serretti & 
Olgiati, 2004). A meta-analysis of five different factor models in SZ, MDD, BD, and 
patients with anxiety disorders revealed five factors (affective, positive, negative, 
disorganized, and cognitive processing) (van Dorn et al., 2016). A more recent approach 
accounting multidimensionality are hierarchical or bi-factorial models assuming broader 
general domains and additional sub-domains (Reise et al., 2007; Shevlin et al., 2017). 
Investigation of three psychopathological scales in psychotic disorders indicated one 
general psychosis dimension, two dimensions of affective and non-affective psychosis 
and five additional sub-dimensions (Reininghaus et al., 2019).  
STUDY I aimed to (1) establish a transdiagnostic psychopathological factor model across 
MDD, BD, and schizophrenia spectrum disorders (SSD) patients covering mood, anxiety, 
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and psychotic symptomatology and (2) to explore whether the data would support a 
hierarchical model. Using five psychopathological scales with a total of 104 symptoms 
and N=1,182 patients, an exploratory and confirmatory cross-validation approach in two 
samples revealed a statistically valid five factor model comprising the factors depression, 
negative syndrome, positive FTD, paranoid-hallucinatory syndrome, and increased 
appetite. The extracted factors were intercorrelated with the negative syndrome and 
depression factors showing largest coefficients. Additionally, two second-order factors 
showing a comparable fit to unitarian models were extracted: (I) negative/affective 
comprising depression, negative syndrome, and increased appetite, and (II) positive 
symptoms including positive FTD and the paranoid-hallucinatory syndrome.  
STUDY I was able to confirm results from previous studies in general population (Shevlin 
et al., 2017) and in psychotic patients (Reininghaus et al., 2013) in a transdiagnostic 
sample. 
The factor increased appetite emerged as a novel dimension that has been previously 
only reported in MDD patients showing weight/appetite disturbance factors (Li et al., 
2014) but not in psychotic patients. In STUDY I, increased appetite was predominantly 
present in BD patients and was correlated with antidepressant medication but with 
negligible effects.  
Unsurprisingly, factors clustered with DSM-IV categories since diagnoses rest upon 
symptoms. Still, our identified factors were more or less present in all diagnoses 
confirming clinical experience (Kircher et al., 2018) as well as neurobiological findings 
(Chang et al., 2018; Goodkind et al., 2015). 
 
2.2. STUDY II: Psychopathological syndromes across affective and 
psychotic disorders correlate with gray matter volumes 
 
Reference: Stein F, Meller T, Brosch K, Schmitt S, Ringwald K, Pfarr JK, Meinert S, Thiel K, 
Lemke H, Waltemate L, Grotegerd D, Opel N, Jansen A, Nenadić I, Dannlowki U, Krug A, Kircher 
T. Psychopathological syndromes across affective and psychotic disorders correlate with gray 
matter volumes. Schizophr Bull. 2021. DOI: 10.1093/schbul/sbab037. (IF 7.96) 
 
The hypothesis stating that particular psychopathological dimensions have a common 
brain structural correlate across affective and psychotic disorders has not been 
confirmed, yet (Wernicke, 1900). Evidence for shared GMV alterations across disorders 
is given by meta-analyses pooling results of single diagnostic categories (Goodkind et 
al., 2015), showing common alterations in the dorsal anterior cingulate and bilateral 
insulae across disorders. Most previous studies focused on the investigation of 
associations between psychopathological factors and GMV in single diagnosis 
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categories that especially exhibit symptoms of such factors [i.e. paranoid-hallucinatory 
syndrome predominately in SZ] albeit these symptoms have been reported in other 
single diagnosis categories, too [i.e. psychotic symptoms in MDD patients (Johns et al., 
2004; Varghese et al., 2011)]. Studies investigating the association of transdiagnostic 
symptom dimensions and GMV are lacking. Based on findings of categorical 
comparisons and results from dimensional studies correlating one symptom complex in 
one disorder, it is reasonable to hypothesize that associations of psychopathological 
factors and local GMV previously detected in one disorder cut across affective and 
psychotic disorders.  
Given the limitations of previous studies, STUDY II investigated the relationship of regional 
GMV and data driven transdiagnostic psychopathological factors derived from STUDY I 
in a sample of N=1,069 patients. Using voxel-based morphometry (VBM) whole brain 
and region of interest (ROI) multiple regression analyses, results of STUDY II confirmed 
the hypothesis of shared GMV alterations associated with psychopathology across 
disorders. The paranoid-hallucinatory syndrome was negatively associated with GMV of 
the right fusiform and left middle frontal gyri. Positive FTD was negatively correlated with 
the right middle frontal gyrus. Further ROI analyses confirmed a number of previous 
results in single diagnostic categories including negative associations of the negative 
syndrome with the bilateral frontal opercula, the positive FTD with the amygdala-
hippocampus complex as well as the paranoid-hallucinatory syndrome with the bilateral 
thalami, left angular gyrus, left postcentral gyrus, and the left posterior cingulate gyrus. 
Interaction analyses of psychopathological factors and DSM-IV categorical diagnoses 
were performed to rule out potential effects driven by unequally distributed diagnostic 
categories. Results showed no interaction. Additionally, results from the total sample 
(N=1,069) were replicated in an age and sex matched sub-sample (same n per 
diagnosis), too, which again strengthens the hypothesis of shared transdiagnostic brain 
structural correlates.  
In short, STUDY II offers three new insights: (1) associations of psychopathology and 
GMV were independent of formal diagnosis, (2) regression analyses were performed 
independently of the current state of patients, preventing subgroup effects that may arise 
when applying categorical approaches, (3) illness severity (e.g. life time cumulative 
duration of hospitalizations) moderated the associations of psychopathology and GMV 
emphasizing the significance of illness aspects other than clinical diagnosis. Finally, the 
reported diagnostically independent brain structural correlates of symptom dimensions 




2.3. STUDY III: State of illness-dependent associations of neuro-cognition 
and psychopathological syndromes in a large transdiagnostic cohort 
 
Reference: Stein F, Schmitt S, Brosch K, Meller T, Pfarr JK, Ringwald K, Lemmer G, Meinert S, 
Lemke H, Waltemate L, Thiel K, Franz M, Preuss UW, Metzger FG, Nagels A, Nenadić I, 
Dannlowski U, Kircher T, Krug A. State of illness-dependent associations of neuro-cognition and 
psychopathological syndromes in a large transdiagnostic cohort. (submitted) 
 
Since there is well documented evidence for shared risk factors (Lee et al., 2019; Uher 
& Zwicker, 2017) and brain changes (Goodkind et al., 2015; Patel et al., 2020) across 
affective and psychotic disorders, it is reasonable to assume transdiagnostic neuro-
cognitive correlates of psychopathology, as well. Comparable to brain structural 
correlates, most previous studies focused on formal comparisons of neuro-cognition 
between patient groups and a healthy control group. While meta-analyses in MDD 
patients showed small to medium effect sizes of neuro-cognitive impairment (Bora et al., 
2013), in BD patients specifically executive functioning and working memory appear to 
be the most impaired (Mann-Wrobel et al., 2011). In addition, meta-analyses of SZ 
patients indicated an impairment of a broad spectrum of neuro-cognitive domains being 
most pronounced in verbal memory, motor skills and executive functioning (Dickinson et 
al., 2007). Transdiagnostic investigations of neuro-cognition across MDD, BD, and SZ 
showed differences between patient groups and healthy controls in all cognitive domains. 
However, motor speed was the only domain that separated affective and psychotic 
disorders with SZ patients performing worst and MDD and BD were located between SZ 
and HC performance on motor speed (Huang et al., 2020). These findings give evidence 
for characteristics different from formal diagnosis better differentiating patient groups 
(Lee et al., 2017). The dimensional, transdiagnostic investigation of neuro-cognition 
revealed a number of associations between neuro-cognition and psychopathological 
factors. For the psychopathological factors drawn from STUDY I these include previous 
correlations of positive FTD with executive functioning (Nagels et al., 2016) and negative 
symptoms with working and episodic memory (Delawalla et al., 2006). However, 
investigation of positive (Delawalla et al., 2006) and affective (Zhu et al., 2019) symptoms 
indicated no correlations with neuro-cognition. Further, studies suggested current 
severity and specifically the course of illness to be critically involved in neuro-cognition, 
indicating neuro-cognitive impairments during acute episodes but not in remission 
(Bowie et al., 2018; Zaremba et al., 2019). Based on the results of previous studies 
STUDY III aimed to (1) investigate the association of transdiagnostic psychopathology 
factors and neuro-cognition using partial correlation analyses corrected for age, sex, 
verbal IQ, years of education, and DSM-IV diagnostic categories, (2) explore the relation 
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to current state of illness, and (3) to test moderating effects of illness severity on the 
neuro-cognition – psychopathology associations. Results of STUDY III (N=1,064) showed 
differential correlations of neuro-cognition and psychopathological factors. Irrespective 
of the current state of disorder, the factors negative syndrome, positive FTD and the 
paranoid-hallucinatory syndrome showed largest correlation coefficients. These 
correlations included verbal fluency (categorical task), verbal working/episodic memory, 
and executive functioning. Corroborating previous results, state-dependent correlations 
emerged. In acute patients with a chronic course, positive FTD and the paranoid-
hallucinatory syndrome were correlated with verbal episodic memory, while these 
correlations were not present in acute patients with remission between episodes. Acute 
patients with remission between episodes exhibited correlations of the negative 
syndrome with attention, verbal fluency, executive functioning, and verbal working 
memory and positive FTD with executive functioning. In line with previous studies, no 
correlations between psychopathological factors and neuro-cognition were present in 
remitted patients. Clinical variables [i.e. age of onset, illness severity] moderated the 
associations of the negative syndrome and positive FTD with neuro-cognition. This is in 
line with previous meta-analytic studies showing SZ patients with youth disorder onset 
having severe deficits whereas patients with late-onset retained cognitive functioning 
(Barder et al., 2013). The absence of moderating effects of clinical variables on the 
neuro-cognition associations with the paranoid-hallucinatory syndrome might be 
explained by being more responsive to antipsychotic medication than for example 
negative syndromes (Huhn et al., 2019; Veerman et al., 2017).  
 
2.4. STUDY IV: Psychopathological dimensions of formal thought disorder 
and their relation to gray and white matter brain structure in affective and 
psychotic disorders 
 
Reference: Stein F, Buckenmayer E, Brosch K, Meller T, Schmitt S, Ringwald KG, Pfarr JK, 
Steinsträter O, Enneking V, Grotegerd D, Heindel W, Meinert S, Leehr E, Lemke H, Thiel K, 
Waltemate L, Winter A, Hahn T, Dannlowki U, Jansen A, Nenadić I, Krug A, Kircher T. 
Psychopathological dimensions of formal thought disorder and their relation to gray and white 
matter brain structure in affective and psychotic disorders. (submitted).  
 
Although FTD is a core symptom of SZ (Kircher et al., 2018), studies have shown 
elevated thought disorder in MDD and BD as well (Kircher et al., 2014). Further scientific 
significance for FTD as a core psychiatric syndrome is given by its prognostic features 
as it is a predictive factor for conversion from at-risk mental states to disorder onset or 
new episodes as well as for illness severity [i.e. patients with FTD have higher risk for 
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inpatient treatment (Roche, et al., 2015a)]. Studies on the dimensional factorial structure 
of this phenotype revealed one to six factors (Andreasen & Grove, 1986; Kircher et al., 
2014; Toomey et al., 1997). However, results remain heterogeneous, especially the 
factorial structure of FTD across affective and psychotic disorder remains largely elusive. 
Previously, studies have shown one negative/poverty dimension (Nagels et al., 2013), 
whereas positive FTD has been divided into two to five dimensions in SZ patients 
(Cuesta & Peralta, 1999; Roche et al., 2015b).  
Besides the transdiagnostic investigation of individual FTD dimensions, there is also a 
need for examining neuroanatomical correlates of this phenotype. Previous research on 
neuroanatomical substrates of FTD focused on the investigation of SZ patients. Positive 
FTD has been reported to be negatively correlated with GMV clusters of the bilateral 
superior temporal gyri, inferior frontal gyri, middle, medial and frontal gyri, and the 
amygdala-hippocampus complex (Cavelti et al., 2018; Sumner et al., 2018). Negative 
FTD was shown to be negatively associated with GMV of the bilateral insula, amygdala, 
and precuneus (Cavelti et al., 2018; Palaniyappan et al., 2015). In addition to GMV 
alterations, white matter fractional anisotropy (FA) has been used to investigate 
structural connectivity. In SZ, a general disconnectivity (Rolls et al., 2020) as well as a 
structural language disconnectivity (Horn et al., 2012) has been reported. Based on 
previous research on aphasia patients and FTD as a phenotype in SZ, the left uncinate 
fascicle and inferior fronto-occipital fascicle form part of the ventral language pathway, 
whereas the dorsal language pathway is constituted by the superior longitudinal fascicle 
and the arcuate fascicle (Cavelti et al., 2018). In addition, the cingulum bundle (Bopp et 
al., 2017; Hilal et al., 2020) and the anterior thalamic radiation (Hilal et al., 2020; Viher 
et al., 2018) have been reported to be implicated in FTD, previously too.  
STUDY IV aimed to untangle both FTD phenotype and brain correlates across disorders. 
Exploratory and confirmatory cross-validation in two samples were used to examine the 
factorial structure of FTD in N=1,071 patients with affective and psychotic disorders. 
Latent factor scores of this analysis were used to investigate the association between 
FTD phenotype factors and GMV as well as FA. Interaction analyses were performed to 
test whether results were driven by DSM-IV single diagnostic categories. 
Results indicated a three factor model including the factors verbosity, emptiness, and 
disorganization. This study extended previous factor models of FTD to a transdiagnostic 
model which also could be replicated in a matched sample.  
FTD factors were differentially associated with gray and white matter brain structure. 
Verbosity was negatively associated with a GMV cluster comprising parts of the temporo-
occipital language junction and positively with two fiber tracts [i.e. right posterior cingulum 
bundle and right inferior longitudinal fascicle]. This GMV cluster is part of the Wernicke 
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speech area which has been associated with FTD in a number of studies (Horn et al., 
2009; Kircher et al., 2018). Further evidence is given from studies investigating aphasia 
patients linking this anatomical structure to semantic paraphasia and neologisms (Stark 
et al., 2019) coinciding with the verbosity factor of the present study as it includes 
derailed speech. The association of verbosity and the right inferior longitudinal fascicle 
as part of the semantic ventral stream (Herbet et al., 2018) is supported by previous 
studies, showing the inferior longitudinal fascicle to be implicated in lexical access 
(Catani & Dawson, 2017).  
The emptiness factor was negatively correlated with GMV in the left hippocampus, 
thalamus and posterior cingulate gyrus, coinciding with results of previous studies 
(Cavelti et al., 2018; Palaniyappan et al., 2012; Sumner et al., 2018). No associations 
were present for emptiness and white matter FA.  
Finally, the factor disorganization was not associated with GMV but with white matter FA. 
Results included a negative association the bilateral anterior thalamic radiation and a 
positive association with the hippocampal part of the right cingulum bundle. These 
findings corroborate previous results as altered FA in the anterior thalamic radiation has 
been reported in BD (Niida et al., 2018) and SZ (Mamah et al., 2010) patients and has 
been associated with global FTD language scores (Viher et al., 2018).  
Importantly, the results drawn in STUDY IV did not interact with DSM formal diagnosis 
(factor x DSM-IV diagnostic category), pointing to diagnosis independent associations of 
FTD and gray and white matte brain structure.  
In summary, STUDY IV provides first large-scale evidence for FTD factors being 
differentially correlated with gray and white matter anatomical brain structures across 
affective and psychotic disorders. As there was no correlation between gray and white 
matter brain structures implicated in FTD in this study, STUDY IV speculates the same 












3. GENERAL DISCUSSION 
This dissertation provides an insight into recent approaches investigating the 
neurobiology of the major psychiatric disorders [i.e. MDD, BD, SSD] on a dimensional, 
data driven level.  
STUDY I established a cross-validated, data driven factor model of psychopathological 
symptoms across affective and psychotic disorders comprising five factors [i.e. 
depression, negative syndrome, positive FTD, paranoid-hallucinatory syndrome, 
increased appetite] confirming H1. In addition, the extracted factors were not specific for 
single diagnostic categories pointing to a diagnosis shared phenomenology. H2 could 
also be confirmed as first order factors loaded on second order factors with comparable 
model fit.  
The factor model of STUDY I was used for brain morphometric correlational analyses in 
STUDY II. Results indicated diagnosis-independent associations of current 
psychopathology and GMV which is in line with H4. Further ROI based analyses 
confirmed results from previous studies investigating single disorders, verifying H3.  
Furthermore, psychopathological factors from STUDY I were used to examine neuro-
cognitive correlates in STUDY III. STUDY III indicated associations of neuro-cognition and 
psychopathological factors in a state of illness-dependent manner confirming H5. Results 
showed that almost all cognitive domains were implicated albeit to different degrees. 
Positive FTD and the negative syndrome showed most pronounced associations that 
were additionally moderated by aspects other than clinical diagnosis [i.e. illness severity, 
age of disorder onset].  
Finally, STUDY IV aimed to investigate FTD as core psychiatric syndrome in more detail 
across diagnoses. Results on the dimensional factorial structure of FTD revealed a three 
factor model. In a further step, these FTD factors were associated with gray and white 
matter brain structure. As hypothesized, gray and white matter alterations previously 
reported in SZ only, were present across diagnosis, approving H6 and providing first 
evidence of common neurobiology substrates involved in FTD across affective and 
psychotic disorders.  
 
3.1. Dimensional Psychopathology 
Given the limitations of traditional psychiatric classification systems and the failure to 
validate these taxonomic distinctions regarding etiological aspects, there is emerging 
evidence for the validity of promising new approaches (Feczko et al., 2019; Hengartner 
& Lehmann, 2017). Hereof, dimensional investigations can be used as a basis for novel 
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group stratification. STUDY I and STUDY IV of this dissertation introduced a new factorial 
model across patients suffering from MDD, BD, and SSD.  
STUDY IV provided evidence for FTD being present across diagnoses. STUDY IV 
extended previous factor analytic research revealing three FTD dimensions (i.e. 
verbosity, emptiness, disorganization) across disorders corroborating results from 
previous studies in SZ patients (Roche et al., 2015b). 
In STUDY I, five factors were extracted. All of the five factors were present in all disorders 
investigated, mirroring previous studies (Conley et al., 2007; Dutta et al., 2011; Johns et 
al., 2004; Upthegrove et al., 2016; Varghese et al., 2011) on the overlapping 
phenomenology across disorders. When comparing the factor dimensions extracted in 
STUDY I to previous factor analytic studies, high levels of correspondence can be 
observed. Most previous studies partly focusing on psychotic disorders revealed factor 
models including depressive, psychosis related, negative and disorganization 
dimensions (Serretti et al., 2001; Serretti & Olgiati, 2004; van Dorn et al., 2016). This 
dissertation extended previous studies on psychotic patients by additionally investigating 
affective disorders, again pointing to a shared phenomenology across disorders that is 
also reflected by neurobiological studies (Anttila et al., 2018; Chang et al., 2018; 
Goodkind et al., 2015; Uher & Zwicker, 2017).  
In addition, the extracted factors of STUDY I were intercorrelated. Specifically the 
depression and negative syndrome factor were correlated, corroborating results from a 
previous study investigating the general population (Shevlin et al., 2017). This 
relationship points to a considerable heterogeneity across negative and depressive 
symptomatology (Krynicki et al., 2018), leading to the question whether these two factors 
are combined into one factor in larger samples (Shevlin et al., 2017). Still, it is 
questionable that this observation is caused by the scales used to assess depressive 
and negative symptomatology that may contain depressive aspects when assessing 
negative symptoms (Shevlin et al., 2017).  
The factor increased appetite of STUDY I emerged as a new dimension. In dimensional 
factor analyses, this dimension has only been reported in an atypical MDD subtype (Li 
et al., 2014). Interestingly, this factor was predominantly present in BD reflecting results 
from previous studies reporting atypical depression to be more frequent in BD than MDD 
(Benazzi, 2005; Łojko et al., 2015).  
Moreover, STUDY I aimed to test whether a hierarchically structured model would better 
fit the data than unitary models. Therefore second-order modeling was performed, 
focusing on latent traits sharing variance of several sub-domains (Shevlin et al., 2017). 
Recently, several studies proposed hierarchically or bifactorial models to be better fitted 
than unitary models (Ahmed et al., 2018; Anderson et al., 2018; Reininghaus et al., 2016; 
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Shevlin et al., 2017). Specifically bifactorial models testing non-redundant, explained 
variance have been increasingly supported. Several studies reported such models 
comprising a general psychopathology factor (e.g. Caspi et al., 2014; Lahey et al., 2012). 
Results of STUDY I indicated comparable fits between the unitary and hierarchically 
structured model. Yet, it is questionable whether models building on more global factors 
[i.e. the p factor] are sufficient to explain the etiology and phenomenology across 
disorders.  
 
3.2. Neurobiological underpinnings of dimensional psychopathology 
Based on the assumption proposed long ago (Wernicke, 1900) of a shared 
pathophysiology across disorders that has been supported by several studies showing 
large neurobiological overlapping (Anttila et al., 2018; Chang et al., 2018; Goodkind et 
al., 2015; Koutsouleris et al., 2015; Lalousis et al., 2021; Uher & Zwicker, 2017), STUDIES 
II, III, and IV aimed to shed light on the neuro-anatomical and neuro-cognitive correlates 
across the major psychiatric disorders. The factors derived from STUDIES I and IV were 
associated with MRI brain structural measures including gray and white matter (only 
STUDY IV). 
The depression factor derived from STUDY I did not correlate with GMV and only weakly 
with verbal fluency and executive functioning. These findings support previous studies 
reporting chronicity and cumulative severity of depression to be a better predictor than 
current psychopathology (Grieve et al., 2013; Zaremba et al., 2018a, 2018b).  
Brain structural analysis of the negative syndrome (STUDY II) indicated a negative 
correlation with the bilateral frontal opercula volumes, a well-known finding from studies 
investigating SZ patients (Bergé et al., 2011; Bora et al., 2011; Kim et al., 2017). 
Additionally, several correlations to neuro-cognitive functioning in acute patients were 
present including attention, verbal fluency, executive functioning, and verbal memory. 
Further, this relationship was moderated by illness aspects other than clinical diagnosis 
highlighting the importance of more complex models integrating dimensional 
psychopathology and neurobiological measures.   
The FTD factors in both STUDIES II and IV were differentially associated with gray and 
white matter brain structure. Both studies validated findings from studies investigating 
SZ patients only. Brain structures implicated in FTD included the GMVs of the right 
middle frontal gyrus, left temporo-occipital language junction, left hippocampus, and the 
left thalamus. Integrity of white matter microstructural circuits implicated in FTD were the 
right inferior longitudinal fascicle, the bilateral anterior thalamic radiation as well the 
posterior and hippocampal part of the cingulum bundle. These brain structures have 
been reported in numerous studies on speech in aphasia (Binder et al., 2009; Fridriksson 
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et al., 2009, 2018; Hilal et al., 2020) as well as in FTD (Cavelti et al., 2018; Horn et al., 
2009; Palaniyappan et al., 2015; Sumner et al., 2018; Viher et al., 2018). Results of 
STUDIES II and IV provided first evidence for common neurobiological structures involved 
in FTD across the major psychiatric disorders indicating further core regions besides the 
traditional anatomical language structures [i.e. Broca area, Wernicke area, dorsal and 
ventral stream (Hickok & Poeppel, 2007)] being relevant to impaired speech. On a neuro-
cognitive level, positive associations of positive FTD (factor derived from STUDY I) to 
verbal episodic memory in patients with a chronic course and to executive functioning in 
acute patients emerged. The GMV cluster negatively associated with FTD in STUDY II is 
part of the prefrontal cortex which has in turn previously reported to be related to 
executive functioning (Orellana & Slachevsky, 2013), indicating a complex 
interrelationship between brain structure, psychopathology and executive functioning.  
GMV correlates of the paranoid-hallucinatory syndrome reported in STUDY II included a 
negative association with the right fusiform and left middle frontal gyri. Both anatomical 
structures have been reported previously in SZ (Mucci et al., 2019; Nenadic et al., 2010; 
Padmanabhan et al., 2015; Palaniyappan et al., 2012; Stan et al., 2020). Furthermore, a 
meta-analysis indicated that reductions in the right fusiform gyrus have largest effect 
sizes (van Erp et al., 2018). Results provided by this dissertation indicate a network of 
temporal and frontal regions implicated in hallucinations and delusions across disorders 
that needs further validation. Only weak associations between neuro-cognitive measures 
and the paranoid-hallucinatory syndrome were found in this dissertation which might 
reflect better treatment response (Huhn et al., 2019; Veerman et al., 2017).  
Finally, interaction analyses in STUDIES II and IV revealed no results, pointing to 
diagnosis independent associations between psychopathology and brain structure, also 
mirroring results from other MRI (Chang et al., 2018; Goodkind et al., 2015; Kaczkurkin 
et al., 2018; Patel et al., 2020), molecular genetics (Anttila et al., 2018; Pettersson et al., 
2016), and environmental risk (Uher & Zwicker, 2017) studies proposing large biological 
overlap across disorders. Genetic and environmental factors impact the developing brain 
at distinct time points with differential intensity. Affected networks or locations might 
depend on the factors impacting the brain. Networks being involved during development 
may regulate psychopathological symptoms after disorder onset.  
In the end, this dissertation hints at the need for more complex models integrating 
psychopathology, neuro-anatomy, and neuro-cognition.  
 
3.3. Limitations 
Some limitations should be noted for the studies reported in this dissertation. First, in all 
four studies, diagnostic categories were unequally distributed since the MDD group was 
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the largest. The dimensional factor models in STUDY I and STUDY IV might be biased by 
different sample sizes. However, following the idea of no points of rarity equally 
distributed diagnostic categories might have resulted in different loadings on the factors 
but not in a different factorial model. Yet, this hypothesis needs to be confirmed by further 
studies applying the factor models proposed in this dissertation.  
Second, in brain structural STUDIES II and IV associations of psychopathology factors 
and GMV were based on current symptoms ignoring past psychopathology. Current 
symptoms might be an indication for state-independent anatomical alterations outlasting 
current symptoms. Still, the investigation of both lifetime psychopathology and 
longitudinal factor models as well as brain structural correlates would help to better 
understand the underlying pathophysiology.  
Third, in STUDIES II and IV, acute pharmacological treatment was accounted for, using 
three dummy coded variables considering the intake of antidepressants, mood 
stabilizers, and antipsychotics. It is unclear whether the lifetime intake of psychotropic 
medication might have biased our results. Albeit factors from STUDY I were merely 
associated with medication, a potential influencing effect cannot be excluded which might 
be applicable for STUDY III, too.  
Fourth, the results presented in this dissertation were restricted to MDD, BD and SSD 
patients. In order to implement a comprehensive dimensional model, mental disorders 
besides the major psychiatric disorders need to be integrated as well.  
Finally, numerous tests were performed, particularly in STUDY III. Although rigorous 
correction for multiple testing was applied in all studies, there is still a risk of type I errors. 
Therefore, the factorial models presented in this dissertation need to be replicated in 
independent, comparable cohorts. Gaining a better understanding of the neurobiological 
underpinnings across disorders, results from brain structural and neuro-cognitive 
STUDIES II, III, and IV need to be validated, as well.  
 
3.4. Integration and implications 
This dissertation provided evidence for the feasibility of dimensional approaches by 
establishing transdiagnostic factor models and by linking specific factors to brain 
structural and neuro-cognitive measures across disorders. Results endorsed the 
hypothesis of particular symptom complexes (i.e. syndromes/factors) sharing common 
(neuro-) biological mechanisms independent of ICD or DSM diagnostic categories 
(Chang et al., 2018; Goodkind et al., 2015; Kaczkurkin et al., 2018; Patel et al., 2020). 
While the results reported in this dissertation support hierarchically structured 
psychopathology models as proposed by other studies (Reininghaus et al., 2019; Shevlin 
et al., 2017), further research on the exact number of factors and levels across mental 
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disorder is needed. Even though initiatives as the studies reported here or Hi-TOP (Kotov 
et al., 2017) might be a starting point for a new topology or ultimately nosology in 
psychiatry, it is unclear whether such approaches can replace diagnostic categories. 
While there is support for completely abandoning traditional classification systems 
(Hengartner & Lehmann, 2017), a double tracked attempt, integrating categorical and 
dimensional definitions (Helzer et al., 2006) might achieve a better understanding of the 
etiology of mental disorders, as well. Retaining traditional classifications systems in 
clinical practice might be useful in terms of providing specificity and consistency (Helzer 
et al., 2006) across multiple nations. However, adding dimensional aspects to these 
systems would open up a completely new window to etiological research across 
disorders. An example for such an approach might be the study by Shankman et al. that 
adapted the structural clinical interview for DSM by adding dimensional severity scales. 
Results of this study indicated superior psychometric properties of the combined 
assessment of categorical and dimensional measures when compared to categorical 
diagnoses only (Shankman et al., 2018). Nevertheless, before adding or exclusively 
implementing such dimensional measures, the utility and validity of the dimensional 
models proposed within and across disorders needs further investigation in terms of 
replicating studies and longitudinal designs testing the stability of these models. Besides 
the implementation of transdiagnostic dimensional models, there is also a need to 
validate these models in terms of etiological measures including molecular genetics, 
neuro-anatomy and function, and environmental risk (Conway et al., 2019). 
Finally, not only the etiological validity but rather the predictive validity of dimensional 
psychiatry needs to be further investigated, e.g. by machine learning models. Hereof, 
further research is needed to test whether dimensional compared to categorical 
approaches can adequately predict onset, conversion, and course of disorder. Even 
though, several attempts have been made to determine a set of prediction factors, there 
is still a need to examine the interplay of multiple metrics across disorders (Ermers et al., 
2020).  
In the end, this dissertation hints at the benefits of dimensional approaches. Even 
though, further investigation is needed to implement dimensional approaches in clinical 
practice as well as research, a dimensional nosology raises the possibility to significantly 
improve treatment and therapy across diagnosis as current treatments are based on 
research building on traditional diagnostic categories, resulting in weak to moderate and 
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For a long time, traditional classification systems have been used to categorize mental 
disorders into strict classes based on a set of specific and standardized criteria. Such 
classifications assume a clear cut off between disorders. However, research using these 
classification systems fail to identify transdiagnostic markers and “points of rarity” 
separating mental disorders. Categorical approaches are limited by the large 
neurobiological overlapping of phenomenology as well as molecular genetics, neuro-
anatomy and function, and environmental risk across disorders. Moreover, categorical 
approaches merely consider characteristics above and below the given categorical 
thresholds using not otherwise specified diagnoses, not fitting to other officially specified 
categories. Given the limitations of categorical approaches, dimensional factor models 
can be used as a valuable framework providing significant progress for the 
understanding of the neurobiology of the major psychiatric disorders (major depressive 
disorder, bipolar disorder, schizophrenia spectrum disorder). 
Previous studies show a range of different factor models, indicating that descriptive 
psychopathology might be organized in a bifactorial or hierarchical framework. However, 
there is still a lack of comprehensive factorial models comprising a broad range of 
symptoms across the major psychiatric disorders.  
Moreover, the neuro-anatomical and neuro-cognitive correlates of transdiagnostic 
psychopathological factors remain largely elusive. Categorical studies on overlapping 
gray matter volume alterations across disorders compared to a healthy control group 
show paralimbic and heteromodal regions to be commonly altered across disorders. In 
addition, the transdiagnostic investigation of neuro-cognitive measures shows large 
overlaps and comparable results across disorders and domains with motor speed being 
the only domain separating disorders.  
To overcome the reported obstacles, the studies underlying this dissertation investigate 
the factorial structure of a broad range of psychopathological symptoms across affective 
and psychotic disorders. Further, dimensional factors are used to determine the 
underlying neuro-anatomical and neuro-cognitive correlates of descriptive 
psychopathology. 
STUDY I demonstrates a cross-validated factor model comprising five first order and two 
second order factors, supporting the use of hierarchical models. The extracted first order 
factors (depression, negative syndrome, positive formal thought disorder, paranoid-
hallucinatory syndrome, increased appetite) are present in all diagnostic categories, 
suggesting a diagnosis-shared phenomenology.  
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STUDY II examines the brain structural correlates of the factors derived from STUDY I. 
Results include a negative association of the negative syndrome with the bilateral frontal 
opercula. Positive formal thought disorder is negatively associated with the right middle 
frontal gyrus and with the left amygdala-hippocampus-complex. The paranoid-
hallucinatory syndrome is negatively associated with two whole brain clusters (right 
fusiform gyrus and left middle frontal gyrus) as well as regions-of-interest including the 
left angular gyrus, bilateral thalami, left postcentral gyrus and left posterior cingulate 
gyrus.  
Investigating the neuro-cognitive correlates of psychopathological factors, STUDY III 
indicates state of illness-dependent associations in almost all cognitive domains. While 
positive formal thought disorder and the negative syndrome show most pronounced 
correlations, no or only weak correlations emerge for the other factors.  
Finally, STUDY IV investigates formal thought disorder in more detail. Results indicate a 
three factor model (verbosity, emptiness, disorganization) that is differentially associated 
with gray and white matter brain structure. The verbosity factor is negatively associated 
with gray matter volume of the temporo-occipital language junction and positively with 
the white matter microstructure of the inferior longitudinal fascicle and the posterior part 
of the cingulum bundle. Emptiness is negatively associated with the gray matter volume 
of the left hippocampus and thalamus but not with white matter. The disorganization 
factor associates with the white matter structure of the bilateral anterior thalamic radiation 
and with the hippocampal part of the right cingulum bundle.  
In conclusion, this dissertation can be interpreted as a first effort overcoming the 
limitations given by previous categorical approaches. The psychopathological factor 
models reported are linked to brain structural and neuro-cognitive measures, supporting 
the view of diagnosis shared and independent biological mechanisms. The studies of 
this dissertation open up completely new approaches for pathogenic and etiological 
research. Dimensional methods as applied in this dissertation constitute the basis for a 
new taxonomy that can in a next step be used to improve prediction, treatment and 












Seit geraumer Zeit werden traditionelle Klassifizierungssysteme dazu verwendet, 
psychische Störungen anhand einer Reihe spezifischer und standardisierter Kriterien in 
diverse Klassen einzuteilen. Diese Vorgehensweise nimmt eine klare Abgrenzung 
zwischen einzelnen psychischen Störungen an. Kategorialen Studien ist es bisher 
jedoch nicht gelungen diagnosespezifische Marker sowie Seltenheitspunkte, welche die 
einzelnen Diagnosekategorien trennen, zu identifizieren. Kategoriale Ansätze sind durch 
die neurobiologischen Überschneidungen von Phänomenologie sowie molekularer 
Genetik, Neuroanatomie und -funktion und Umweltrisiken bei verschiedenen Störungen 
begrenzt. Darüber hinaus werden Charakteristika ober- und unterhalb spezifischer 
Diagnosekriterien nur hinreichend mittels nicht näher spezifizierten Diagnosen, welche 
nicht die Kriterien anderer offizieller Diagnosen erfüllen, berücksichtigt. 
Angesichts der Einschränkungen kategorialer Ansätze, können dimensionale 
Faktormodelle als wertvolle Ergänzung verwendet werden, um das neurobiologische 
Verständnis psychiatrischer Störungen (Majore Depression, bipolare Störung, 
Schizophrenie-Spektrum-Störungen) zu verbessern.  
Obwohl frühere Studien eine Reihe von verschiedenen Faktorenmodellen innerhalb 
bestimmter Diagnosekategorien zeigen, die darauf hinweisen, dass die deskriptive 
Psychopathologie bifaktoriell oder hierarchisch organisiert sein könnte, steht die 
umfassende Untersuchung eines breiten Spektrums von Symptomen noch aus. 
Darüber hinaus sind die neuroanatomischen und neurokognitiven Korrelate 
transdiagnostischer, psychopathologischer Faktoren nach wie vor weitgehend 
unbekannt. Kategoriale Studien zu überlappenden Veränderungen des Volumens der 
grauen Substanz zeigen, dass paralimbische und heteromodale Regionen bei 
psychiatrischen Störungen verglichen zu einer gesunden Kontrollgruppe gleichermaßen 
verändert sind. Im Hinblick auf neurokognitive Domänen bestehen deutliche 
Überlappungen. Lediglich die motorische Geschwindigkeit scheint eine Trennung 
zwischen den Störungen zu ermöglichen. Ziel der Studien dieser Dissertation ist es, die 
dimensionale Struktur eines breiten Spektrums von psychopathologischen Symptomen 
über affektive und psychotische Störungen hinweg zu untersuchen. Auf Basis der 
extrahierten Faktoren werden die zugrundeliegenden neuroanatomischen und 
neurokognitiven Korrelate genauer untersucht.  
STUDIE I zeigt ein kreuzvalidiertes Faktorenmodell mit fünf Faktoren erster Ordnung 
und weiteren zwei Faktoren zweiter Ordnung, was die Verwendung von hierarchischen 
Modellen unterstützt. Die extrahierten Faktoren erster Ordnung („depression, negative 
syndrome, positive formal thought disorder, paranoid-hallucinatory syndrome, increased 
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appetite“) sind in allen diagnostischen Kategorien vorhanden, was auf eine 
diagnoseübergreifende Phänomenologie hindeutet.  
STUDIE II untersucht die hirnstrukturellen Korrelate der aus STUDIE I abgeleiteten 
psychopathologischen Faktoren. Das „negative syndrome“ ist mit einer Volumen 
Reduktion in den bilateralen frontalen Opercula assoziiert, wohingegen der Faktor 
„positive formal thought disorder“ mit dem rechten mittleren frontal Gyrus und mit dem 
linken Amygdala-Hippocampus-Komplex negativ assoziiert ist. Der Faktor „paranoid-
hallucinatory syndrome“ ist mit dem rechten fusiformen Gyrus als auch dem linken 
mittleren frontal Gyrus sowie weiteren „regions-of-interest“, darunter der linke Gyrus 
angularis, bilaterale Thalami, der linke postzentrale Gyrus und der linke posteriorer 
cinguläre Gyrus negativ assoziiert.  
Die Untersuchung neurokognitiver Korrelate der psychopathologischen Faktoren zeigt in 
STUDIE III Assoziationen zu einer Vielzahl kognitiver Domänen, welche vom aktuellen 
Patientenzustand abhängig sind. Während die Faktoren „positive formal thought 
disorder“ und „negative syndrome“ ausgeprägte Korrelationen zur Neurokognition 
aufweisen, können diese nicht für die anderen Faktoren nachgewiesen werden.  
Schließlich ist es Ziel von STUDIE IV formale Denkstörungen genauer zu untersuchen. 
Es kann ein drei Faktoren Modell mit dem Faktoren „verbosity“, „emptiness“ und 
„disorganization“ ermittelt werden, was differentiell mit der grauen als auch weißen 
Substanz korreliert. Der Faktor „verbosity“ ist negativ mit dem Volumen der grauen 
Substanz des temporo-occipitalen Sprachnetzwerks und positiv mit der weißen 
Substanz des inferioren longitudinalen Faserbündels und des posterioren Teils des 
cingulären Faserbündels assoziiert. Der Faktor „emptiness“ korreliert negativ mit der 
grauen Substanz des linken Hippocampus und des Thalamus, nicht jedoch mit den 
Faserbündeln der weißen Substanz. Der Faktor „disorganization“ ist mit der bilateralen 
anterioren Thalamusstrahlung und mit dem hippocampalen Teil des rechten cingulären 
Faserbündels assoziiert.  
Zusammenfassend kann diese Dissertation als eine erste Arbeit interpretiert werden, 
welche die Einschränkungen kategorialer Ansätze überwindet. Die berichteten 
psychopathologischen Faktormodelle sind mit hirnstrukturellen und neurokognitiven 
Maßen verknüpft, was die Auffassung von diagnoseübergreifenden und unabhängigen 
biologischen Mechanismen unterstützt. Die Studien dieser Dissertation eröffnen völlig 
neue Ansätze für die pathogenetische und ätiologische Forschung. Dimensionale 
Methoden, wie sie in dieser Dissertation angewandt werden, bilden die Grundlage für 
eine neue Taxonomie, welche in einem nächsten Schritt zur Verbesserung der 
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Background: There is an ongoing discussion about which neurobiological correlates or symptoms separate the
major psychoses (i.e. Major Depressive Disorder MDD, Bipolar Disorder BD, and Schizophrenia SZ). Psychopath-
ological factor analyseswithin one of these disorders have resulted inmodels including one to five factors. Factor
analyses across themajor psychoses using a comprehensive set of psychopathological scales in the same patients
are lacking. It is further unclear, whether hierarchical or unitarian models better summarize phenomena.
Method: Patients (n=1182)whomet DSM-IV criteria for MDD, BD, SZ or schizoaffective disorderwere assessed
with the SANS, SAPS, HAMA, HAM-D, and YMRS. The sample was split into two and analyzed using explorative
and confirmatory factor analyses to extract psychopathological factors independent of diagnosis.
Results: In the exploratory analysis of sample 1 (n = 593) we found 5 factors. The confirmatory analysis using
sample 2 (n= 589) confirmed the 5-factor model (χ2 = 1287.842, df= 571, p b .0001: CFI= 0.932; RMSEA=
0.033). The 5-factors were depression, negative syndrome, positive formal thought disorder, paranoid-
hallucinatory syndrome, and increased appetite. Increased appetite was not related to medication. None of the
factors was specific for one diagnosis. Second order factor analysis revealed two higher order factors: negative/
affective (I) and positive symptoms (II).
Conclusion: This is the first study delineating psychopathological factors in a large group of patients across the
spectrum of affective and psychotic disorders. In future neurobiological studies, we should consider
transdiagnostic syndromes besides the traditional diagnoses.
© 2020 Elsevier B.V. All rights reserved.
1. Background
The division into dementia praecox and manic-depressive illness by
Emil Kraepelin (Kraepelin, 1919) is still implicitly held in contemporary
diagnostic systems. Kraepelin described these two disorders as separate
nosological entities with putatively different etiology, symptomatology
and outcome. Although this dichotomy is clinically useful, more than a
century of intensive research has not been able to define a “point of rar-
ity” between schizophrenia and affective disorders. There is now strong
evidence that psychotic (schizophrenia, SZ; schizoaffective disorder,
SZA) and affective disorders (Major Depressive Disorder, MDD; Bipolar
Disorder, BD), henceforth referred to as Major Psychoses, are overlap-
ping regarding outcome, course and phenomenology. Importantly, re-
cent neurobiological research found the Major Psychoses across
diagnoses share familial and molecular genetic risks (Brainstorm
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Consortium et al., 2018), environmental risks (Uher and Zwicker, 2017),
brain changes (Chang et al., 2018; Goodkind et al., 2015) and other neu-
robiological “markers” (Goldsmith et al., 2016). Therefore it is time to
rethink the taxonomy of the Major Psychoses, and several approaches
have been made to overcome the scientific deadlock (Allardyce et al.,
2007; Dikeos et al., 2006; Reininghaus et al., 2019, 2016). In the past,
neurobiological research usually has focused on comparing one phe-
nomenologically diagnosed patient group to a healthy control group
(e.g. regarding brain structure, risk alleles, cytokines, etc.). This ap-
proach does not take into account the overlapping phenomenology
and neurobiology across the psychotic and affective disorders (Allsopp
et al., 2019). We therefore suggest a new avenue for group stratification
that can in a second step, be validated using external criteria (course of
illness, neurobiologicalfindings, functional outcome, etc.). This novel ty-
pology may result in a new taxonomy or ultimately nosology.
We propose, that descriptive psychopathology across the psychotic
and affective disorders constitutes a basis for novel group stratification
(Conway et al., 2019). In the past, the standard approach has been factor
analyses of symptoms using operationalized scales. Factor analyses
across the major psychoses using a comprehensive set of psychopatho-
logical scales in the same patient groups are lacking.
1.1. Factor models within diagnoses
There are many studies on psychopathological factor analyses
within one of the clinically definedDSMor ICDdiagnoses. Factormodels
in psychotic disorders (SZ or schizophrenia spectrum) have revealed
three to eleven factors using one or two psychopathological scales in
the same patients (Emsley et al., 2003; Liddle, 1987; Peralta et al.,
1997; Peralta and Cuesta, 1999; Rapado-Castro et al., 2010). In DSM-IV
defined MDD, studies reported one (Li et al., 2014) to four factors.
Within patients suffering from BD, studies showed five to seven factors
(Baek et al., 2018; Hanwella and de Silva, 2011; Harvey et al., 2008; Sato
et al., 2002).
1.2. Hierarchical models within diagnoses
A more recent approach accounting for multidimensionality of psy-
chopathological symptoms is hierarchical or bifactorial models. Both
models assume one or more general domains that are considered to
be conceptually broader than sub-domains (Reise et al., 2007; Shevlin
et al., 2017). While bifactorial models test the nonredundant, explained
variance by competing general and specific factors, second-order
modeling focusses on latent traits that share variance of several sub-
domains (Shevlin et al., 2017).
In psychotic disorders (DSM-IV, using The Comprehensive Assess-
ment of Symptoms and History, CASH (Andreasen et al., 1992) there
was evidence for a low- and higher-order factor structure showing
four primary factors (depression, catatonia, bizarre delusions, paranoid
delusions) andfive second-order factors (bipolar negative-mania, disor-
ganization, psychomotor retardation, hallucinations, grandiosity)
(Peralta et al., 2013). A cross-cultural study using the Brief Negative
Symptom Scale (BNSS) in SZ/SZA (DSM-IV/ICD-10) showed a hierarchi-
cally structured model displaying five first order (anhedonia, asociality,
avolition, blunted affect, alogia) and two second order factors (Ahmed
et al., 2018). Comparing unitary, bifactorial and multidimensional
models in psychotic disorders, a general psychosis factor including neg-
ative and positive symptoms and five specific factors (negative symp-
toms, positive symptoms, mania, disorganization and depression)
(Reininghaus et al., 2013) have been extracted.
1.3. Factor models across diagnoses
There are only very few studies investigating the dimensional factor
structure across disorders. A meta-analysis of five studies (using the
PANSS or BPRS) focusing on SZ patients and a small MDD, BD and
other diagnosis (e.g. anxiety) sample showed in a split-half exploratory
and confirmatory analysis five factors: affective, positive, negative, dis-
organized, and cognitive processing (Van Dorn et al., 2016). Confirma-
tory analyses of six competing factor models investigating lifetime
symptoms (OPCRIT), including SZ patients, delusional disorder and BD
(DSM-IV) indicated that dimensions are better described by a 4- or 5-
factor model than by models with fewer factors (Serretti and Olgiati,
2004). Symptom dimensions in a sample of SZ and MDD patients
(DSM-III-R) could be explained by a 3-factor model encompassing de-
pression, positive and negative symptoms (Romney and Candido,
2001). In a study investigating lifetime symptoms (OPCRIT), four symp-
tom dimensions (excitement, psychotic, depression, and disorganiza-
tion) could be identified in a group of SZ, delusional disorder, BD and
MDD patients (DSM-IV) (Serretti et al., 2001).
Some studies found also hierarchical solutions across diagnoses.
Using the OPCRIT a study (Reininghaus et al., 2016) showed that symp-
tom dimensions in BD and SZ (DSM-IV) can be best described by a
bifactor model with one general transdiagnostic psychosis factor and
five additional dimensions (positive, negative, disorganized, manic
and depressive). Investigation of PANSS items in BD, SZ and SZA
(DSM-IV) showed evidence for a bifactorial model with better fit than
in a unitary 5-factor model (Anderson et al., 2018). Another study ap-
plying the PANSS, YMRS, MADRS in SZ, SZA or BD with psychotic fea-
tures (DSM-IV) revealed one general psychosis dimension, two
dimensions of affective and non-affective psychosis, and additional
five specific dimensions (Reininghaus et al., 2019).
1.4. Present study
In summary, previous studies that have included patients across di-
agnoses often (1) are limited to two diagnoses or even to subgroups
within a diagnosis (e.g. BD with psychotic features), (2) have assessed
patient reported lifetime psychopathology, which is of somewhat lim-
ited validity, (3) have focused on acute inpatients not giving tribute to
(partly or fully) remitted patients, and/or (4) only have assessed a lim-
ited number of symptoms mostly focusing on psychotic or affective
symptoms, assessed by no more than three operationalized rating
scales, thus not covering a broad psychopathological spectrum. (5) Fur-
ther, it is unclear whether hierarchical or non-hierarchical models best
describe the factor structure across diagnoses. To overcome these limi-
tations, our first aim was to establish a psychopathological factor
model in a large, transdiagnostic group of MDD, BD, and schizophrenia
disorders (henceforth referred as SZ) patients using a comprehensive
set of psychopathological scalesmeasuringmood, anxiety and psychotic
symptomatology (i.e. SANS, SAPS, HAM-D, HAMA, and YMRS). Our sec-
ond aim was to explore whether our data support a hierarchical model.
2. Method
2.1. Participants
All patients were recruited as part of the FOR2107 cohort, a bi-
central (cities of Marburg und Münster, Germany) study focusing on
the neurobiology of the major psychoses (for detailed information see
(Kircher et al., 2018b) and www.for2107.de). Patients were recruited
from in- and out patients of the university hospitals in Marburg and
Münster, from the departments of participating local hospitals in
about 50 km radius around these cities, and via postings in local news-
papers and flyers. Exclusion criteria for this study were IQ b 80, history
of head trauma or unconsciousness, medical illnesses (cancer, autoim-
mune diseases, and infections), neurological illness, and substance de-
pendence. After excluding patients with incomplete data, we analyzed
1182 (remitted, acute and chronic) in- and out-patients (aged 18–65)
who met DSM-IV criteria for MDD (296.2× or 296.3×, n = 887, f =
571/m = 316), BD (292.5×, 292.6×, 292.7×, 296.0×, 296.4×, 296.5×,
296.6×, 296.7× or 296.8×, n = 151, f = 81/m = 70), and SZ (295.X,
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295.7 n = 144, f = 65/m = 79)) (see Tables 1a and 1b). All patients
were interviewed at the Departments of Psychiatry and Psychotherapy
in Marburg or Münster, Germany. Procedures were approved by the
local Ethics Committee according to the Declaration of Helsinki and pa-
tients gave written informed consent to the study protocol. Patients re-
ceived a finical compensation after finishing the participation.
2.2. Psychopathological assessment
Psychopathological phenomena were assessed during a clinical in-
terview including SCID-I and different psychopathological scales. Rat-
ings were done during or immediately after the interview. We
restricted our analyses to rater based scales to increase reliability and
to reduce heterogeneity. The following scales were used: the SANS
and the SAPS are two six-point scales that assess current positive or
negative symptoms (Andreasen, 1984, 1983). Within our study the
temporal assessment was the last two weeks. The HAMA includes 14
symptoms, rated on a five-point scale, that are related to psychic and so-
matic anxiety during the last seven days (Hamilton, 1959). The HAM-D
contains 17 items measuring depressive symptoms during the last
seven days. The scaling in some variables is defined by increasing sever-
ity, while others are rated by equal-valued terms (Hamilton, 1960). The
Young Mania Rating Scale (YMRS) is a 5-point scale consisting of 11
items measuring current manic symptoms (Young et al., 1978). All in-
terviewers were psychologists, familiar with and trained in the evalua-
tion of the respective psychopathological scales. Interrater reliability
(ICC) achieved excellent values of N0.86 in all scales.
2.3. Statistical analyses
Descriptive statistics for age, sex, age of onset, functioning, edu-
cational level and sum scores of the psychopathological scales were
calculated and summarized in Table 1a and 1b. First we separated
the sample (n = 1182) into two samples (sample 1: n = 593 and
sample 2: n = 589) using the “mindiff” package (Papenberg, 2019)
in R (R Development Core Team, 2008) taking into account sex and
age as covariates. This package separates groups by minimizing dif-
ferences with regard to certain criteria. In a next step we carried
out an explorative factor analysis (EFA) of sample 1 to investigate
the factorial symptom structure of several psychopathological scales.
Therefore we used the Statistical Package for Social Science (IMB,
SPSS), version 22, Armonk, NY. Varimax rotation was chosen to be
consistent with previous studies. As criterion for factor extraction
we chose the Kaiser's (Kaiser, 1960) eigenvalue greater-than-one,
since this standard procedure is probably one of the most reliable
methods (Peralta and Cuesta, 1999). Due to different scaling z-
transformed values were used for analyses.
The global syndrome-rating scores of SANS and SAPS were not in-
cluded in the analyses, because theymerely summarize single symptom
ratings. Due to no variance, items 5a and b of HAM-D (measuring loss of
weight) and item 9 of YMRS (disruptive-aggressive behavior) were not
included in the analysis. According to the scree plot, we examined the
factor structure of a 4, 5, and 6-factor model. Suitability of data was
checked using Kaiser-Meyer-Olkin test (KMO) (Kaiser, 1974) and
Bartlett's test of sphericity (Bartlett, 1937). The internal consistency of
the extracted explorative factors was testedwith Cronbach's alpha coef-
ficients (Cronbach, 1951).
In a next step a confirmatory factor analysis (CFA)was performed on
the second sample using Mplus (version 8). Goodness of fit was mea-
sured with: chi-square significance test, comparative fit index (CFI)
(Bentler, 1990), and Root Mean Square Error of Approximation
(RMSEA) (Steiger, 1990). The chi-square test tests the strict null hy-
pothesis of a perfect model fit. Because of this strictness and because
the chi-square value increases not only with deviance of the replicated
variance-covariance matrix from the empirical matrix but also with
sample size. CFI values equal or N0.90 can be classified as acceptable
(Bentler, 1990). RMSEA values equal or b0.05 indicate good fit
(Browne and Cudeck, 1993). The model was estimated using the MLR
method (Muthén and Muthén, 1998). Additionally, we tested the
model for the whole sample (n = 1182). Finally, we also performed a
second order analysis investigating factors of higher order (within the
whole sample).
Table 1a
Characteristics of sample 1 n = 593 patients.






Age 37.16 (13.27) 41.78 (12.28) 38.22 (12.1) p = .02a
(4.11)
Sex f = 286, m = 158 f = 41, m = 35 f = 33, m = 40 p = .003
Educational level (in years) 13.19 (2.81) 13.72 (2.81) 12.15(2.88) p = .003b
(5.85)
Age of onset 26.23 (12.86) 24.44 (10.78) 22.17 (8.59) p = .024c
(3.78)
SANS 7.26 (8.09) 6.14 (7.92) 12.95 (11.19) p b .0001d
(15.67)
SAPS 0.7 (2.07) 2.08 (3.54) 9.48 (13.19) p b .0001e
(92.78)
HAMA 12.28 (8.63) 9.37 (7.56) 8.85 (6.34) p b .0001f
(8.28)
HAM-D 8.61 (6.75) 6.21 (5.72) 5.84 (4.66) p b .0001g
(9.11)
YMRS 1.38 (1.94) 3.21 (4.68) 2.33 (4.56) p b .0001h
(15.27)
GAF 63.8 (16.24) 58.58 (17.07) 52.05 (17.6) p b .0001i
(13.53)
Values indicate means of total values and standard deviations (SD) (in brackets). Post hoc differences between groups:
a =MDD b BD.
b =SZ b MDD.
c =SZ b MDD.
d =MDD b SZ; BD b SZ.
e =MDD b SZ; BD b SZ.
f =MDD N SZ, BD.
g =SZ b MDD; SZ b BD.
h =MDD b BD,SZ.
i =MDD N SZ.
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To satisfy traditional clinical convention we performed one-way
ANOVAs studying latent mean differences in factor scores across the
categorical diagnosis groups using Tuckey's post hoc test.
Moreover, we were interested in differences in factor scores regard-
ing the clinical status of the patients. Based on remission cut-offs for
each scale (Andreasen et al., 2005; Berk et al., 2008; Heinig et al.,
2017; Riedel et al., 2010) and on the information about the clinical
course (operationalized by item 90 of the OPCRIT 4 (McGuffin et al.,
1991), we divided patients into three groups. The specific criteria
were as follows: “acute” status: SANS global ratings (items 7, 12, 16,
and 21) N2 (Andreasen et al., 2005), SAPS global ratings (items 7, 20,
25, 34) N2 (Andreasen et al., 2005), HAMA sum score N19 (Heinig
et al., 2017), HAM-D sum score (17 item version) N6 (Riedel et al.,
2010), and YMRS sum score N4 (Berk et al., 2008). When exceeding
one of the above remission criteria cut-off, the patient was classified
as “acute”. A “chronic course” was defined as item 90 of the OPCRIT 4
scoring N2, a clinical course with times in full “remission” was defined
as item 90 of the OPCRIT 4 scoring ≤2. The groups were defined as
“acute patients with a chronic course”, as “acute patients with full re-
mission between episodes”, and “remitted patients” at the time of psy-
chopathological assessment.
3. Results
The sociodemographic and clinical characteristics of the participants
are described in Tables 1a and 1b.
3.1. Explorative factor analysis
The KMO score of sample adequacy was 0.771 indicating that the
data fit the factor model well. Barlett's test of sphericity showed highly
significant values (χ2 = 2283.291, df = 5151). Small factor loadings
b0.5 were not considered (Pituch and Stevens, 2015). After varimax ro-
tation, the determined eigenvalue N1 criterion and the suggestion of the
ScreePlot, factor analyses revealed a 5-factor structure (Table 2). The
symptoms summarized in factor models with less than five factors did
not make sense clinically, such that patients with combinations of
these symptoms would be extremely unusual and rare. A factor model
withmore than five factors could be declined due to less internal consis-
tency, implausible factors and less plausibility in the dimensional
content.
The 5-factor model included the following factors (Table 2)
(explaining 24.35% of variance): depression (α = 0.9), negative syn-
drome (α = 0.901), formal thought disorder (α = 0.732), paranoid-
hallucinatory syndrome (α = 0.749) and increased appetite (α =
0.834).
3.2. Confirmatory factor analysis
In order to confirm the explorative results we performed confirma-
tory factor analyses in our second sample. We could confirm the previ-
ously explorative assumed model. Model fit indices for sample 2 (n =
589) showed good fit (χ2 = 1011.951, df = 571, p b .0001, CFI =
0.925, RMSEA=0.036). Additionallywe tested the fit indices for sample
1 which has been explorative tested before. Again indices showed good
fit (χ2 =1172.759, df=571, p b .0001, CFI=0.90, RMSEA=0.042). To
test whether our model fit the whole sample, we performed confirma-
tory factor analysis in the whole sample (n = 1182) showing a good
fit. (χ2 = 1287.842, df = 571, p b .0001, CFI = 0.932, RMSEA = 0.033),
too. Confirmatory factors were intercorrelated (Table 3). We also tested
models that included higher order factors (see Fig. 1). Factor 1, 2 and 5
loadedon a different higher order factor (Inegative/affective) as opposed
to factors 3 and 4 (II positive symptoms) (χ2 = 1332.922, df = 575,
p b .0001, CFI = 0.928, RMSEA= 0.033).
3.3. Association between symptom dimensions and categorical disorders
To satisfy traditional clinical convention, latent standardized factor
scores of each patientwere tested for differences betweenDSM-IV diag-
nostic categories. There was no difference across diagnostic groups for
the factor increased appetite (F (2, 1179) = 0.8; p = .45), but for the
other factors (Table 4 and Fig. 2).
Table 1b
Characteristics of sample 2 n = 589 patients.
Major depressive disorder (n = 443) Bipolar disorder (n = 75) Schizophrenia disorders (n = 71) Group comparison (F-values in brackets)
Age 37.15 (13.23) 41.79 (12.66) 38.2 (11.01) p = .016a
(4.16)
Sex f = 285, m = 158 f = 40, m = 35 f = 32, m = 39 p = .003
Educational level (in years) 13.07 (2.63) 13.96 (2.87) 12.42 (2.42) p = .003b
(5.84)
Age of onset 26.25 (12.73) 25.37 (12.01) 22.18 (9.47) p = .039c
(3.26)
SANS 8.16 (9.38) 5.13 (6.76) 15.07 (13.43) p b .0001d
(21.14)
SAPS 0.7 (2.21) 2.87 (4.83) 10.97 (11.44) p b .0001e
(145.8)
HAMA 13.07 (8.81) 9.44 (7.08) 10.72 (8.1) p b .0001f
(7.24)
HAM-D 8.59 (6.3) 6.67 (5.91) 7.73 (6.1) p = .037g
(3.31)
YMRS 1.52 (2.38) 4.8 (6.87) 3.07 (4.74) p b .0001h
(29.43)
GAF 62.08 (15.84) 61.74 (11.39) 48.49 (16.79) p b .0001i
(20.15)
Values indicate means of total values and standard deviations (in brackets). Post hoc differences between groups:
a =MDD b BD.
b =MDD b BD; SZ b BD.
c =SZ b MDD.
d =MDD b SZ; BD b SZ; MDD N BD.
e =MDD b SZ; MDD b BD; BD b SZ.
f =BD b MDD.
g =BD b MDD.
h =MDD b BD, SZ.
i =MDD N SZ; BD N SZ.
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3.4. Relationship between factors and clinical status
Investigation of the relationship between factor scores and the clin-
ical status of patients revealed differences in almost all factors (F (2,
1179) = 78.24; p ≤ .0001) (see Table 5). “Acute patients with chronic
course” had the highest loadings on our factors while “remitted pa-
tients” had the lowest loadings.
“Acute patients with chronic course” did not differ from “acute pa-
tientswith remission between episodes” in factor 5 (increased appetite)
(F (2, 586) = 9.23; p = .1).
3.5. Factor 5: increased appetite
The increased appetite dimension differed between patients with
(n = 814) and without (n = 329) psychopharmacological medication
F (1, 1141) = 9.43; p = .002, η2 = 0.008). Regarding antidepressive
medication patients with and without antidepressive medication dif-
fered significantly in the factor increased appetite (F (1, 1141) =
13.49; p ≤ .0001¸ η2 = 0.01). We further tested the relationship to spe-
cific subclasses of antidepressive medication. We found significant but
Table 2
Explorative factors: 5-factor model of Sample 1 n = 593.
Factor Item Symptom Loading Cronbach's alpha
1 (Depression) HAMA6 depressed mood 0.706 0.9
HAMD1 depressed mood 0.671
HAMA2 tension 0.635
HAMA1 anxious mood 0.615
HAMDa7 fatigability 0.615
HAMD9 somatic symptoms - general 0.608
HAMD2 work and activities 0.602
HAMA4 insomnia 0.602
HAMA5 intellectual 0.594
SANS17 recreational interests and activities 0.582
HAMDa1 social withdrawal 0.554
HAMD12 anxiety - psychic 0.531
SANS15 physical anergia 0.517
HAMD13 anxiety - somatic 0.515
2 (Negative syndrome) SANS6 lack of vocal inflections 0.795 0.901
SANS3 paucity of expressive gestures 0.776
SANS2 decreased spontaneous movements 0.763
SANS1 unchanging facial expression 0.752
SANS5 affective nonresponsivity 0.751
SANS8 poverty of speech 0.662
HAMD16 retardation 0.566
3 (Positive formal thought disorder) SAPS29 illogicality 0.764
SAPS28 incoherence 0.701
SAPS24 repetitive or stereotyped behavior 0.682
SAPS30 circumstantiality 0.576
SAPS31 pressure of speech 0.558
SAPS27 tangentiality 0.527
YMRS6 speech (rate and amount) 0.503
4 (Paranoid-hallucinatory syndrome) SAPS8 persecutory delusions 0.667 0.749
SAPS1 auditory hallucinations 0.588
SAPS13 somatic delusions 0.573
SAPS14 delusions of reference 0.559
SAPS5 olfactory hallucinations 0.539
5 (Increased appetite) HAMDa4 increased eating 0.860 0.834
HAMDa3 appetite increase (want to eat) 0.833
HAMDa5 carbohydrate craving or eating 0.515
Table 3
Correlations between confirmatory factors within the whole sample.
Factor Factor Estimate S.E. Est./S.E. Two-tailed p-value
Factor 2 (negative syndrome)
Factor 1 0.32 0.03 10.04 0.0001
Factor 3 (positive formal thought disorder)
Factor 1 0.02 0.03 0.67 0.51
Factor 2 0.08 0.04 2.14 0.003
Factor 4 (paranoid-hallucinatory syndrome)
Factor 1 0.06 0.05 1.25 0.21
Factor 2 0.27 0.06 4.26 0.0001
Factor 3 0.49 0.1 4.67 0.0001
Factor 5 (increased appetite)
Factor 1 0.18 0.03 5.82 0.0001
Factor 2 0.02 0.03 0.48 0.63
Factor 3 0.03 0.04 0.89 0.37
Factor 4 0.05 0.05 1.16 0.25
Bold printed numbers indicate significant correlations between factors. Fig. 1. Confirmatory factor model.
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negligible effects for: Noradrenergic and Specific Serotonergic Antide-
pressants (NaSSAs) (F (1, 1091) = 17.31; p ≤ .0001; η2 = 0.016) and
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) (F (1,
1091) = 4.45 p = .03; η2 = 0.004). Patients medicated with NaSSAs
(factor 5: mean 0.25, SD 0.84) had more appetite than those patients
without NaSSAs (factor 5: mean − 0.01, SD 0.52). Patients receiving
SNRIs also had more appetite (factor 5: mean 0.07, SD.64) than those
without (factor 5:mean− 0.01, SD.53).
There were no significant associations for: Selective serotonin reup-
take inhibitors (SSRI) (F (1, 1091) = 1.15; p = .283; η2 = 0.001),
norepinephrine–dopamine reuptake inhibitors (NDRI) (F (1, 1091) =
0.512; p = .474; η2 = 0.001), agomelatine (F (1, 1091) = 3.39; p =
.06; η2 = 0.003), anticonvulsants (F (1, 1091) = 0.56; p = .45; η2 =
0.001), and lithium (F (1,1091) = 0.69; p = .4; η 2 = 0.001). The use
of neuroleptics was also not associated with “increased appetite” (F (1,
1091) = 1.33; p = .25; η2 = 0.001).
4. Discussion
4.1. Main findings
This is the first study cross-validating the underlying latent variables
(i.e. factor dimensions) in two, transdiagnostic samples ofMDD, BD, and
SZ patients using a comprehensive set of psychopathological scales
measuring affective, anxiety, and psychotic symptomatology (SANS,
SAPS, HAM-D, HAMA, YMRS). The symptoms can be best explained by
a statistically valid five-factor model. First-order dimensions in the con-
firmatory five-factor model were depression, negative syndrome, posi-
tive formal thought disorder, paranoid-hallucinatory syndrome, and
increased appetite. Cronbach's Alpha showed good internal consistency
within the extracted factors. We could further reveal second-order fac-
tors: (I) negative/affective comprising depression, negative syndrome
and increased appetite, and (II) positive symptoms includingpositive for-
mal thought disorder and the paranoid-hallucinatory syndrome.
4.2. Comparison with previous factor models
While most previous studies were restricted to inpatients focusing
on acute symptomatology, we considerably expanded this previous ap-
proach in terms of acute, chronic and remitted patients across three di-
agnostic categories, who we examined with five psychopathological
scales covering a broad range of symptoms. The present study revealed
five factors across the major psychoses.
Additionally, first order factors were intercorrelated showing that
symptoms are related and occur simultaneously. Specifically, the corre-
lation of the factors depression and negative symptoms is worth men-
tioning (r = 0.32) since this finding was reported in a previous study
investigating psychotic symptoms in the general population (Shevlin
et al., 2017).
We did not observe a separate anxiety factor in our analyses. Anxiety
symptoms segregated in the first factor depression (see Table 2) show-
ing that these symptoms are closely related to depressive
Table 4
Distribution of factors across DSM-IV diagnoses (n = 1182).
Major depressive disorder Bipolar disorder Schizophrenia disorders Group comparison (F-values in brackets)
Depression 0.09 (1.04) −0.35 (0.96) −0.23 (0.99) p b .0001a
(17.16)
Negative syndrome −0.03 (0.49) −0.14 (0.37) 0.36 (0.74) p b .0001b
(42.63)
Positive formal thought disorder −0.04 (0.1) 0.04 (0.21) 0.19 (0.35) p b .0001c
(116.06)
Paranoid-hallucinatory syndrome −0.07 (0.13) −0.04 (0.13) 0.45 (0.67) p b .0001d
(239.15)
Increased appetite −0.01 (0.53) 0.07 (0.68) 0.04 (0.48) p = .2
(1.61)
Values indicate means of latent factor scores and standard deviations (in brackets).
Post hoc differences between groups:
a =MDD N BD, SZ.
b =SZ N MDD, BD.
c =SZ N MDD, BD; BD N MDD.
d =SZ N BD, MDD.
Fig. 2. Factor dimensions and diagnostic categories (n = 1182).
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symptomatology. The result has been reported previously in studies of
the general population (Shevlin et al., 2017) and psychotic patients
(Reininghaus et al., 2013).
A meta-analysis of studies using the PANSS and BPRS (Van Dorn
et al., 2016) focusing on SZ patients and small numbers of MDD, BD
and other patients (e.g. anxiety) revealed five factors, i.e. affective,
positive, negative, disorganized, and cognitive processing. While
Van Dorn et al. (2016) used two complementary schizophrenia
scales, we have applied five scales, assessed by the same raters. Our
three factors depression, negative and paranoid-hallucinatory syn-
drome overlapped with those of Van Dorn et al. (2016). The differ-
ences in methodological aspects between the two studies may
explain the different results.
In a study investigating lifetime symptoms with the OPCRIT within
SZ, delusional disorder, BD andMDDpatients, four factorswere defined:
excitement symptoms, psychotic features, depression and disorganiza-
tion (Serretti et al., 2001).We could also find a depression and psychotic
features factor. Nevertheless, we could expand the results of Serretti
et al., 2001 considerably in terms of the evaluation of current psychopa-
thology with a comprehensive set of scales, resulting in a more detailed
factorial structure and showing a novel factor “increased appetite”. The
use of lifetime patient reported psychopathology might be less valid
than assessment of current symptoms.
4.3. Hierarchical models
Some previous studies have shown hierarchically structuredmodels
only in psychotic disorders. Usually there are one or two general factors
and several specific factors (Anderson et al., 2018; Reininghaus et al.,
2013). Our hierarchical model divides psychopathological symptoms
into two main dimensions, namely affective/negative (I) and positive
symptoms (II). Fit indices (RMSEA, CFI) of the confirmatory first order
factormodel and themodel with second order factors were comparable
showing that both solutions are equally valid and explain a comparable
amount of variance. Factors 1, 2, and 5 loaded on higher-order factor I
(affective/negative) while factors 3 and 4 loaded on the second
higher-order factor II (positive symptoms).
Furthermore, our model shows a great overlap with the bifactorial
models in the general population reported by Shevlin et al., 2017 as
well as in psychotic patients (SZ, SZA, delusional disorder,
schizophreniform disorder) using the OPCRIT by Reininghaus et al.,
2013. These authors also reported a depression, negative, disorganiza-
tion and positive symptom dimension similar to our study. However,
within our study formal thought disorders were examined in more
detail with the SANS/SAPS which include disorganized thinking and
speech, into contrast to the scales in other studies.
.
4.4. Categorical diagnoses, course of illness
Although this was not the primary aim of our study, we wanted to
acknowledge traditional clinical convention and showed that our fac-
tors clustered with the existing DSM-IV categories - unsurprisingly,
since the diagnoses mainly rest on the prevailing syndrome a patient
presents with. However, no syndrome was specific for a diagnosis, i.e.
all syndromes were present more (i.e. “increased appetite”) or less in
all diagnoses. This confirms clinical experience (Kircher et al., 2018a)
and recent neurobiological findings, which have not found a “point of
rarity” between diagnoses (Chang et al., 2018; Goldsmith et al., 2016;
Goodkind et al., 2015). An alternative approach for future neurobiolog-
ical studies could be the separation of groups according to their psycho-
pathology transgressing clinical diagnoses (Kaczkurkin et al., 2018).We
and others have shown the feasibility of a syndrome based approach
(Cavelti et al., 2018; Kircher et al., 2001) in structural and functional
brain imaging.
In a further descriptive analysis, we related our factors to course of
illness. The severity of psychopathology in all factors roughly increased
from “remitted patients” across “acute patients with remission between
episodes” to “acute patients with chronic course”, a result with further
confirms the clinical validity of our findings.
4.5. Factor 5 “increased appetite”
The factor “increased appetite” emerged as an independent domain
in our factor solutions. This factor has not been reported in psychotic
disorders but in MDD, previously. Some studies reported a typical de-
creased appetite factor in depression (Romera et al., 2008) while others
showed an increased appetite dimension (Li et al., 2014; Van Loo et al.,
2012). In our study the factor “increased appetite” remained stable
across different models. It has been shown that this factor segregates
if psychopathological scales are appliedwith items capturing vegetative
symptoms (Li et al., 2014; Stewart et al., 1993) as in our study: the
HAM-D has a subscale specifically measuring appetite, so it is conceiv-
able that it came up as a separate factor.
We found associations of SNRIs and NaSSAs with the factor “in-
creased appetite”, but no relation to other antidepressant or antipsy-
chotic medication. However, the effects were negligible (effect sizes
between 0.004 and 0.016) and we do not think they explain this factor.
Table 5
Relationship between factors and clinical status (n = 1182).
Acute patients with chronic course
(n = 170) (1)
Acute patients with remission between episodes
(n = 599) (2)
Remitted patients
(n = 413) (3)
Group comparison
(F-values in brackets)
Depression 0.6 (0.97) 0.41 (0.94) −0.84 (0.47) p b .0001a
(346.67)
Negative syndrome 0.34 (0.77) 0.02 (0.52) −0.17 (0.29) p b .0001b
(64.16)
Positive formal thought disorder 0.09 (0.29) 0.01 (0.19) −0.04 (0.08) p b .0001c
(30.57)
Paranoid-hallucinatory syndrome 0.25 (0.61) −0.02 (0.24) −0.08 (0.1) p b .0001d
(77.57)
Increased appetite 0.11 (0.71) 0.05 (0.57) −0.12 (0.39) p b .0001e
(16.38)
Values indicate means of latent factor scores and standard deviations (in brackets).
Post hoc differences between groups:
a =1 N 2, 3; 2 N 3.
b =1 N 2, 3; 2 N 3.
c =1 N 2, 3; 2 N 3.
d =1 N 2, 3; 2 N 3.
e =1 N 3; 2 N 3.
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Our finding is supported by studies investigating the impact of psycho-
pharmacological medication on symptom dimensions showing that
there is no difference within the dimensions before and after treatment
of SZ patients with antipsychotics (Harvey et al., 1996). Taking these is-
sues together, the factor “increased appetite” is a relevant and some-
what overlooked symptom in the major psychoses that deserves
further investigation.
4.6. Limitations
Our sample purposefully represents roughly the disorder preva-
lences in the population, therefore the MDD group is our largest. Our
primary goal was not to investigate symptom prevalence within cate-
gorical diagnoses, but dimensionally across the disorders. The idea
was that there are no “points of rarity” between the DSM diagnoses,
therefore equal sample sizes for the diagnoses would have contradicted
our approach, for a comparable objective see (Conway et al., 2019). Ad-
ditionally, we think that our factorswould have remained stable, if diag-
nostic subgroups had been enriched, only individual factor loadings
would have changed. We have deliberately analyzed only rater based
scales and not self-rating scales because this reduces heterogeneity
and has limited the number of symptoms/items entering the analyses.
The temporal assessment of the rating scales used was slightly dif-
ferent (HAM-D, HAMA, and YMRS: last week; SANS, SAPS: last
2 weeks). Nevertheless, ratings had a close temporal overlap and were
performed according to the published and validated manuals.
Explained variance of the explorative factors in sample 1was smaller
than in previous studies. Thismight have several reasons. First, previous
studies mostly focused on psychotic disorders which leads to less het-
erogeneity than in our sample. Second, the use of several psychopatho-
logical scales combing a wide range of symptoms might also have
reduced possible variance explained since not every symptom included
in the analyses was present in all patients.
5. Conclusion
The main strength of the present study is the use of a large cohort, a
comprehensive set of psychopathological scales, and the inclusionof pa-
tients with psychotic and affective disorders in acute, chronic, and re-
mitted states, something which has not been examined before. Our
findings give new evidence for a factorial structure across the major
psychoses. These factors may serve as an important and novel addition
to categorical diagnostic approaches (Ahmed et al., 2018) in future
research.
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Introduction: More than a century of research on the neu-
robiological underpinnings of major psychiatric disorders 
(major depressive disorder [MDD], bipolar disorder [BD], 
schizophrenia [SZ], and schizoaffective disorder [SZA]) 
has been unable to identify diagnostic markers. An alter-
native approach is to study dimensional psychopathological 
syndromes that cut across categorical diagnoses. The aim 
of the current study was to identify gray matter volume 
(GMV) correlates of transdiagnostic symptom dimensions. 
Methods: We tested the association of 5 psychopatholog-
ical factors with GMV using multiple regression models 
in a sample of N = 1069 patients meeting Diagnostic and 
Statistical Manual of Mental Disorders, Fourth Edition 
(DSM-IV) criteria for MDD (n = 818), BD (n = 132), and 
SZ/SZA (n  =  119). T1-weighted brain images were ac-
quired with 3-Tesla magnetic resonance imaging and pre-
processed with CAT12. Interactions analyses (diagnosis × 
psychopathological factor) were performed to test whether 
local GMV associations were driven by DSM-IV diagnosis. 
We further tested syndrome specific regions of interest 
(ROIs). Results: Whole brain analysis showed a significant 
negative association of the positive formal thought disorder 
factor with GMV in the right middle frontal gyrus, the 
paranoid-hallucinatory syndrome in the right fusiform, and 
the left middle frontal gyri. ROI analyses further showed 
additional negative associations, including the negative 
syndrome with bilateral frontal opercula, positive formal 
thought disorder with the left amygdala-hippocampus com-
plex, and the paranoid-hallucinatory syndrome with the 
left angular gyrus. None of the GMV associations inter-
acted with DSM-IV diagnosis. Conclusions: We found 
associations between psychopathological syndromes and 
regional GMV independent of diagnosis. Our findings open 
a new avenue for neurobiological research across disorders, 
using syndrome-based approaches rather than categorical 
diagnoses.
Key words:  voxel-based morphometry/transdiagnostic/ 
dimensional/major psychiatric disorders
Introduction
There is strong evidence that psychotic (schizophrenia 
[SZ] and schizoaffective disorder [SZA]—both henceforth 
referred as schizophrenia spectrum disorder [SSD]) and 
affective disorders (major depressive disorder [MDD] and 
bipolar disorder [BD]) (henceforth, together referred to 
as major psychiatric disorders) are overlapping regarding 
symptoms, course, and outcome.1,2 Neurobiological re-
search showed that these major psychiatric disorders 
share familial and molecular genetic risk,3 environmental 
risks,4 structural brain changes,5–8 and other neurobiolog-
ical markers.9 On a phenomenological level, the major 
psychiatric disorders share many syndromes such as de-
pression, mania, and psychosis.10–12
Since research using diagnostic categories might over-
look psychopathological mechanisms across disorders, 
transdiagnostic, dimensional approaches13–15 can serve 
as an important addition to traditional approaches com-
paring diagnostic groups. In studies on a shared psycho-
pathological factor structure across SSD, MDD, and 
BD, 3–5 factors have been delineated.16–19 Most com-
monly paranoid-hallucinatory, depressive, negative, dis-
organized, and manic dimensions can be identified as 
separate dimensions.16,18,20 Confirmatory analyses of  6 
competing factor models revealed that symptom dimen-
sions are better represented by factor models including 4 
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In our own previous study, we cross-validated a 5-factor 
model comprising depression, negative syndrome, 
positive formal thought disorder (pFTD), paranoid-
hallucinatory syndrome, and increased appetite across 
the major psychiatric disorders.2
For a long time,21 it has been hypothesized that par-
ticular syndromes might share a common brain struc-
tural network alteration, independent of the diagnostic 
category.1,5–7,22 But up to now, most studies investigating 
gray matter volume (GMV) alterations across disorders 
focused on categorical approaches.6,7 Using a multimodal 
machine learning approach aiming to classify recent onset 
psychosis and depression revealed no points of rarity on a 
brain structural level indicating comparable GMV across 
psychosis patients with comorbid depressive symptoms 
and patients with recent onset depression.8 This result is 
further supported by a study23 showing that specifically 
in patients with younger age disorder onset, neuroana-
tomical disease signatures fail to separate affective and 
psychotic disorders. Based on these findings, we aim to 
shed light on brain structural correlates of psychopath-
ological factor dimensions across disorders. Below, we 
summarize results of previous voxel-based morphometry 
(VBM) studies on structural correlates of psychopatho-
logical factors. We focus on the neural substrates of the 
5 psychopathological factors derived from our previous 
study.2
The paranoid-hallucinatory syndrome has mostly been 
investigated in studies including SZ patients. There is 
meta-analytical evidence that auditory verbal hallucin-
ations are negatively correlated with GMV in the left in-
sula and right superior temporal gyrus (STG).24 Further 
core regions25 negatively associated with the paranoid-
hallucinatory syndrome are the thalamus,26–28 the left 
planum temporale,29 left anterior cingulate, and the bilat-
eral insulae.30,31
pFTD have been frequently associated with neuroan-
atomical alterations in the left STG, frontal opercula, 
and left middle temporal gyrus, (ie, Wernicke and Broca 
area).32,33 Dimensional analyses of pFTD in SZ patients 
showed negative associations in the bilateral inferior 
frontal gyri, the orbito-frontal cortex (OFC), the middle, 
medial, and superior frontal gyri, the left amygdala-
hippocampus complex, the precuneus, and the insula.34,35
Meta-analyses of negative symptoms in SZ patients 
reported GMV reductions in the OFC, the anterior cin-
gulate cortex, fusiform gyrus, thalamus, caudate, and 
amygdala associated with the severity of negative symp-
toms.36,37 However, results are heterogeneous. Some 
studies reported no association between GMV and nega-
tive symptoms on a whole brain level.38–40
Testing dimensional depressive symptomatology and 
GMV in MDD, there were correlations in the right OFC, 
the left hippocampal gyrus, and the right dorsolateral 
prefrontal cortex.41 Investigation of subclinical depressive 
symptoms in healthy populations revealed inconsistent 
associations in the anterior cingulate, OCF, and thal-
amus.42–44 Nevertheless, several studies found no associ-
ations between GMV and psychopathological measures 
in MDD patients.45–47
The psychopathological factor “increased appetite” 
from our phenomenological study has not been reported 
in previous factor analytical approaches.2 This dimension 
has only been reported within atypical MDD patients.48,49 
One study investigating subtypes of MDD patients in-
dicated that a severely increased appetite MDD subtype 
showed lower surface area in the anterior insula when 
compared to a healthy control group.50 Neurobiological 
research investigating obesity in otherwise healthy con-
trols indicated the amygdala, hippocampus, insula, OFC, 
and the striatum to be central regions of appetite be-
havior.51,52 A study investigating MDD patients revealed 
lower temporo-frontal cortical thickness to be associated 
with obesity (body mass index > 30).53
In summary, most transdiagnostic GMV studies are 
limited by (1) results from studies comparing diagnostic 
categories (as opposed to dimensional investigations), or (2) 
dimensional psychopathological investigations restricted to 
2 diagnostic groups, and/or by (3) investigating one psy-
chopathological dimension not covering the whole psycho-
pathological spectrum. To overcome these limitations, our 
aim was to investigate associations of psychopathological 
dimensions with GMV on a dimensional, transdiagnostic, 
data-driven level across MDD, BD, and SSD. Based on 
previous findings,5,6,8,23 we hypothesize that associations be-
tween psychopathological syndromes and local GMV that 
have previously been detected within one diagnosis, cut 




We included structural magnetic resonance imaging 
(MRI) data of  acute and remitted patients (aged 18–65) 
meeting Diagnostic and Statistical Manual of  Mental 
Disorders, Fourth Edition (DSM-IV) criteria (SCID-I) 
for MDD (296.2X, 296.3X: n = 818, F = 530/M = 288), 
BD (292.5X, 292.6X, 292.7X, 296.0X, 296.4X, 296.5X, 
296.6X, 296.7X, or 296.8X: n = 132, F = 71/M = 61), 
SZ (295.X: n = 74, F = 32/M = 42), and SZA (295.7: 
n  =  45, F  =  24/M  =  21). This MRI sample is a sub-
group of  our previous study on psychopathological 
factors,2 from which, after quality checks of  the brain 
scans  n  =  113 patients had to be excluded, leaving 
N  =  1069 participants for the current analyses (see 
table  1). Patients were part of  the DFG FOR2107 
consortium54 and were interviewed and scanned at 
the Departments of  Psychiatry and Psychotherapy 
Marburg or Münster Universities, Germany. In- and out-
patients were recruited from these Universities and local 
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and Haina, LWL Münster, Germany) and via posting in 
local newspapers and flyers. Exclusion criteria were any 
history of neurological (head trauma or unconsciousness) 
and medical condition, substance dependence, current 
use of benzodiazepines, and IQ ≤80. The assessment of 
psychopathological symptoms and MRI data acquisition 
was performed within the same week. n = 341 patients 
(31.9%) did not receive any psychotropic medication, 
53.5% received antidepressants, 12.1% mood stabil-
izers, and 29.6% antipsychotics at time of  data collec-
tion. Based on DSM-IV criteria, n = 12 MDD (296.24, 
296.34) patients and n = 6 BD (295.04, 296.44, 296.54) 
patients presented with psychotic features. A  small 
number of  participants were diagnosed with a past al-
cohol (n  =  52) or substance (n  =  26) abuse. Patients 
gave written informed consent to study protocols ap-
proved by the local Ethics Committees according to the 
Declaration of  Helsinki. 
MRI Data Acquisition and Preprocessing
MRI data acquisition was done according to an exten-
sive quality assurance protocol.55 In Münster, a 3T MRI 
scanner (Prisma, Siemens, Germany) and a 20-channel 
head matrix Rx-coil were used. MRI data in Marburg were 
obtained using a 3T MRI scanner (Tim Trio, Siemens, 
Germany) and a 12-channel head matrix Rx-coil. At 
both sites, we used a fast gradient echo MP-RAGE se-
quence with a slice thickness of 1.0 mm consisting of 176 
in Marburg and 192 in Münster sagittal orientated slices 
and a field of view of 256 mm. Parameters were differing 
across sites: Marburg: time of repetition [TR]  =  1.9 
seconds, echo time [TE]  =  2.26 milliseconds, inversion 
time [TI]  =  900 milliseconds, flip angle  =  9°; Münster: 
TR = 2.13 seconds, TE = 2.28 milliseconds, TI = 900 milli-
seconds, flip angle = 8°. Before preprocessing, all scans 
were visually inspected regarding artifacts and anatom-
ical abnormalities by a senior clinician (U.D.). Structural 
MRI data were preprocessed56 using default parameters 
as implemented in the CAT12-Toolbox (Computation 
Anatomy Toolbox for SPM, build 1184, Structural Brain 
Mapping group, Jena University Hospital, Germany; 
http://dbm.neuro.uni-jena.de/cat/) building on SPM12 
(Statistical Parametric Mapping, Institute of Neurology, 
London, UK) providing bias-corrected, tissue classified, 
and normalized data ratings. During preprocessing, im-
ages were segmented57 into gray matter, white matter, and 
cerebrospinal fluid. Images were spatially registered, seg-
mented, and normalized58 using a DARTEL algorithm. 
All scans underwent the automated quality assurance, 
using the CAT12 “check data quality using covariance” 
procedure. After preprocessing and the described quality 
assurance protocols, we excluded n  =  113 patients, due 
to major artifacts or abnormalities not accomplishing 





Schizophrenia Spectrum Disorder 
(n = 119; SZ n = 74, SZA n = 45) P (F/χ 2)
Age 36.95 (13.19) 41.03 (11.94) 38.13 (11.81) .003a (5.82)
Sex M = 288, F = 530 M = 61, F = 71 M = 63, F = 56 < .001 (17.53)
Years of education 13.19 (2.74) 14.02 (2.8) 12.61 (2.68) < .001b (8.07)
Age of onset 26.12 (12.62) 24.26 (11.29) 22.46 (9.4) .005c (5.39)
Life time cumulative duration of 
hospitalizations (months)
11.68 (17.84) 33.23 (33.59) 38.46 (38.91) < .001d (96.71)
Duration of current episode 
(months)
22.84 (46.46) 12.92 (35.61) 30.2 (56.93) .093 (2.39)
Verbal IQ 112.67 (13.78) 114.98 (15.62) 111.82 (14.79) .161 (1.83)
Psychopathological factors
 Depression (F1) 0.69 (1.02) −0.33 (0.95) −0.29 (0.88) < .001e (13.83)
 Negative syndrome (F2) −0.06 (0.47) −0.14 (0.36) 0.33 (0.74) < .001f (35.42)
  Positive formal thought disorder 
(F3)
−0.04 (0.1) 0.04 (0.21) 0.19 (0.37) < .001g (107.14)
  Paranoid−hallucinatory syndrome 
(F4)
−0.07 (0.13) −0.03 (0.13) 0.47 (0.71) < .001h (219.5)
 Increased appetite (F5) −0.01 (0.53) 0.09 (0.71) −0.04 (0.51) .12 (2.13)
Note: SZ, schizophrenia; SZA, schizoaffective disorder. Values indicate means and SD (in brackets). Post hoc differences between groups.
aBipolar disorder (BD) > major depressive disorder (MDD).
bBD > MDD, schizophrenia spectrum disorder (SSD).
cMDD > SSD.
dSSD > MDD, BD > MDD.
eMDD > SSD, BD.
fSSD > MDD, BD.
gSSD > BD, MDD; BD > MDD.
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the CAT12 quality criteria, leaving N = 1069 for the cur-
rent study. MRI data sets were spatially smoothed with 
a Gaussian kernel of 8 mm full width at half  maximum.
Statistical Analyses
Multidimensional Factors. Using a cross-validation ap-
proach within 2 samples, we had performed an explora-
tory and confirmatory psychopathological factor analysis 
in our previous study.2The scale for the assessment of 
negative symptoms,59 scale for the assessment of positive 
symptoms,60 Young mania rating scale,61 Hamilton anx-
iety rating scale,62 and the Hamilton depression scale63 
with a total of 104 symptoms were used to identify multi-
dimensional, psychopathological factors across diagnosis. 
Psychopathological data were obtained during a clinical 
interview and were rated immediately afterwards by clin-
ically trained psychologists (for detailed information see, 
Stein et al.2). Interrater reliability achieved excellent values 
of >.86 in all scales. Summarizing the procedures, we di-
vided the total sample and conducted a varimax-rotated 
principal axis factor analysis in the first sample. To validate 
the explorative factor solution, we performed a confirm-
atory factor analysis in the second sample using Mplus64 
(MLR model estimation) showing a good fit: χ 2 = 1287.842, 
df = 571, P < .0001, comparative fit index = 0.932, root 
mean square error of approximation = 0.036. The following 
factors were found in our previous study: depression, neg-
ative syndrome, pFTD, paranoid-hallucinatory syndrome, 
and increased appetite. Latent, standardized factor scores 
for each patient of the current study were used from this 
previous study,2 to test whether the previously established 
dimensional factors were associated with GMV.
Voxel-Based Morphometry Analyses:  Whole Brain Level. 
We used smoothed GMVs and standardized latent factor 
scores for each patient to perform separate linear regres-
sion models for each transdiagnostic factor (not for each 
diagnostic group). Analyses were carried out using SPM12 
(https://www.fil.ion.ucl.ac.uk/spm/). To avoid poten-
tial confounders, we applied several covariates of no in-
terest: age, sex, site and total intracranial volume, and the 
change of one gradient coil.54,55 As previously reported 
in our factor analytic study,2 increased appetite was not 
correlated to antipsychotics, only to intake of serotonin-
norepinephrine reuptake inhibitors and noradrenergic and 
specific serotonergic antidepressants with negligible effects. 
Therefore, we used 3 dummy-coded covariates accounting 
for the intake of at least one antidepressant, mood stabi-
lizer, and antipsychotic. As recommended for VBM ana-
lyses, absolute threshold masking with a threshold value 
of 0.1 was used. Cluster labeling was applied using the 
dartel space Neuromorphometrics atlas (http://www.
neuromorphometrics.com/).
For each psychopathological factor, associations with 
GMV (whole brain) at peak-level threshold P <.05, 
family-wise error (FWE) corrected, and cluster extend 
threshold k = 10 were investigated. To investigate if  our 
transdiagnostic brain correlates were driven by DSM-IV 
diagnostic categories, we performed ANCOVA interac-
tion analyses (diagnostic category × factor) in SPM on 
whole brain level.
Due to the unbalanced distribution of DSM-IV 
categories, in further confirmatory analyses, we used 
whole brain clusters of the total sample and tested them 
as regions of interest (ROIs) in an equally distributed 
sample matched for age and sex (n = 357) (matching was 
performed using the “MatchIt” package65 in R66). We also 
performed ANCOVA interaction analyses in the matched 
sample. For the matched sample, significance level was set 
at α <.05, false discovery rate (FDR) corrected.
Clinical variables, ie, life time cumulative duration of 
hospitalizations,67,68 duration of current episode,69 years 
of education,70,71 and verbal IQ72 were tested for poten-
tially moderating effects on the associations between 
brain structure and psychopathological factor. Therefore, 
eigenvariates (weighted mean) as an approximation of 
mean value inside the clusters were extracted. Moderator 
models (PROCESS macro v3.3 for SPSS,73 model number 
1) were corrected for the same covariates as VBM analyses.
Voxel-Based Morphometry: ROI Analyses. We tested 
whether our 5 psychopathological factors2 were asso-
ciated with GMV across diagnoses, using a ROI ap-
proach. To objectively select ROIs, we performed a 
comprehensive literature search using MEDLINE 
(PubMed.gov interface) and additionally went through 
references in the articles identified. For inclusion of  a 
ROI for our analyses, the following literature selection 
criteria were applied: (1) meta-analyses published after 
2010, or if  a meta-analysis for a factor was not available 
review article in a high ranking journal; (2) investigating 
at least one of  the 5 syndromes in patients with MDD, 
SSD, or BD dimensionally (ie, correlating psychopath-
ological scores with GMV; studies performing a mere 
patient-healthy control design were not included); and 
(3) the ROIs had to be replicated in 2 individual orig-
inal studies, published after 2005. Based on these cri-
teria, the literature search revealed the meta-analyses 
and ROIs listed in table 2.
Masks for the ROIs were created using the “dartel 
space neuromorphometrics” atlas (http://www.
neuromorphometrics.com/) in CAT12. Using the batch 
mode, the search space for each factor and the selected 
ROIs was restricted beforehand. We accounted the 
same covariates as for whole brain analyses using a P 
<.05, peak-level FWE corrected, and k = 10 threshold. 
Since all ROIs were reported to be negatively associ-
ated with the symptom dimensions, we performed one 
sided t tests. Furthermore, interactions analyses were 
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Results
Whole Brain Analyses
In the total sample, the pFTD factor (F3) was nega-
tively associated with GMV in the right middle frontal 
gyrus (MFG) (k = 30 voxels, x/y/z = 34/46/16, T = 4.85, 
Z = 4.82, P = .01, FWE). The paranoid-hallucinatory syn-
drome factor was negatively correlated with GMV in the 
right fusiform gyrus (k = 24 voxels, x/y/z = 38/−21/−20, 
T = 5.08, Z = 5.05 P = .005, FWE) and in the left MFG 
(k  =  27 voxels, x/y/z  =  −32/62/−3, T  =  4.79, Z  =  4.76 
P = .02, FWE) (see figure 1). No FWE-corrected associ-
ation was present for the other factors. Interaction ana-
lyses of diagnostic group × factor in the total sample 
(N = 1069) showed no significant results.
To rule out potential effects of differences in the 
number of patients per diagnoses, we performed multiple 
regression and ANCOVA interaction analyses again in 
the age- and sex- matched subsample (n = 357). We repli-
cated the negative association of the right MFG Cluster 
and pFTD in the matched sample, too (k  =  30 voxels, 
x/y/z = 33/46/16, T = 4.25, Z = 4.2 P = 1.198*10–7, FDR). 
The negative association of the paranoid-hallucinatory 
syndrome and the right fusiform gyrus (k  =  24 voxels, 
x/y/z = 38/−21/−20, T = 4.14, Z = 4.09 P = 1.384*10–4, 
FDR), as well as the left MFG cluster (k  =  27 voxels, 
x/y/z = −33/57/0, T = 4.73, Z = 4.65 P = 9.022*10–6, FDR) 
were also present in the matched sample. Interaction ana-
lyses of diagnostic group × factor showed no significant 
results.
Post hoc moderator analyses of illness variables showed 
a significant moderation of life time cumulative duration 
of hospitalizations on the association of F4 “paranoid-
hallucinatory syndrome” and the right fusiform cluster 
(R2 = .018, F = 20.76; P < .001) and the left MFG cluster 
(R2 = .009, F = 10.01; P = .002). The duration of current 
episode moderated associations of GMV clusters and 
F4 (right fusiform gyrus: R2 =  .01, F = 6.54; P =  .012; 
left MFG: R2 = .011, F = 7.23; P = .007). Both life time 
cumulative duration of hospitalizations (R2  =  .002, 
F = 1.86; P = .173) and the duration of the current epi-
sode (R2 = .002, F = 0.12; P = .727) did not moderate the 
right MFG cluster (F3). Years of education moderated 
the association of pFTD and the right MFG (R2 = .007, 
F = 8.16; P = .004). There was no moderating effect of 
verbal IQ.
ROI Analyses
Based on our literature search, we applied separate ROI 
analyses for each factor, in the total sample. We found 
FWE peak-level corrected GMV negative associations in 
the selected ROIs for the negative syndrome, pFTD, and 
the paranoid-hallucinatory syndrome (see table  3). The 
selected ROIs for the depression and increased appetite 
factor revealed no significant association. Interaction 
analyses (diagnoses × psychopathological factor) re-
vealed no interaction in all ROIs in both the total sample 
and in the age- and sex- matched sample (same n per 
diagnosis).
Table 2. Psychopathological Factors Derived From Our Patients,2 Meta-Analysis or Review Article on Structural Brain Correlates of 
These Syndromes and Selected Regions for Our Region-of-Interest Analysis
Psychopathological Factor Literature Region
Depression (F1) Schmaal et al. (2017)46 Right middle frontal gyrus
Left hippocampus
Bilateral superior frontal gyri




Positive formal thought disorder (F3) Sumner et al. (2018)34; Cavelti et al. (2018)35 Bilateral orbitofrontal cortices
Left superior temporal gyrus
Left planum temporale
Left amygdala-hippocampus complex
Left anterior cingulate gyrus
Bilateral superior temporal gyri
Bilateral amygdalae
Paranoid-hallucinatory syndrome (F4) Mucci et al. (2019)25 Bilateral thalami proper
Bilateral insulae
Bilateral planum temporale
Left anterior cingulate gyrus
Left insula
Bilateral superior temporal gyri
Left angular gyrus
Left postcentral gyrus
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Fig. 1. (A, B) Negative correlations between gray matter volume for (A) positive formal thought disorder and the right middle frontal 
gyrus and (B) between the paranoid-hallucinatory syndrome and the right fusiform and left middle frontal gyrus, family-wise error peak-
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Discussion
Given the limitations of meta-analytic studies pooling 
single DSM diagnoses, our study investigated the rela-
tionship between regional brain volumes and dimen-
sional, transdiagnostic psychopathological syndromes 
in one large sample comprising patients with MDD, 
BD, and SSD. Building on our previous work, we had 
derived 5 psychopathological factors (ie, depression, 
negative syndrome, pFTD, paranoid-hallucinatory syn-
drome, and increased appetite).2 On whole brain level, 
we found negative associations for pFTD with the right 
MFG and the paranoid-hallucinatory syndrome with 
the right fusiform gyrus and the left MFG. Using ROI 
analyses, we were able to confirm a number of previous 
results across diagnoses: The negative syndrome was 
negatively associated with the bilateral frontal opercula, 
pFTD with the left amygdala-hippocampus complex and 
the paranoid-hallucinatory syndrome with the bilateral 
thalami proper, the left postcentral gyrus, the left pos-
terior cingulate gyrus, and the left angular gyrus. Based 
on these findings, we can draw 3 new insights. First, 
there was no interaction effect of DSM-IV diagnostic 
categories × psychopathological factors in all GMV as-
sociations on whole brain level and within the ROI ana-
lyses in both the total sample and in the matched sample 
containing the same n per diagnosis, strengthening our 
assumption of shared transdiagnostic, psychopatholog-
ical factor-local GMV associations74–77 within MDD, BD, 
and SSD. Additionally, whole brain clusters found in the 
total sample could be replicated in the matched sample, 
too. This mirrors meta- or mega-analytic results from 
brain structural,5,6,8,23 molecular genetic genome-wide 
association studies,3,78 immunology,9 and environmental 
factors,4,79 showing large biological overlapping across 
these disorders. In contrast to these previous pooling 
studies, we included only patients from one large study. 
Interestingly, important clinical variables which have pre-
viously been related to brain structural alterations, such 
as life time cumulative duration of hospitalizations67,68 
and duration of the current illness episode,69 did indeed 
moderate the extracted GMV clusters in our study. This 
validates our findings and confirms the significance of ill-
ness aspects other than the clinical diagnosis. Based on 
these converging findings across modalities, we hypoth-
esize that genetic and environmental factors impact the 
developing brain at different times and intensities across 
individuals affected regional brain structure, with the 
particular location/network depending on the individual 
factors. The involved network during development de-
termines the psychopathological syndrome predominant 
later in life after disorder onset. Second, the approach ap-
plied here allowed us to investigate symptom complexes 
such as the paranoid-hallucinatory syndrome across dis-
orders, which has previously been mostly investigated in 
SZ patients. But it is well known that MDD patients also 
show elevated psychotic symptoms.10,11 Regression ana-
lyses were performed independent of the state of patients 
(ie, acute, chronic, and remitted). Thus, our approach is 
less prone to subgroup effects that may arise when ap-
plying categorical approaches. Third, by using whole 
brain and ROI-based approaches, we exploratively tested 
transdiagnostic brain structures on whole brain level and 
identified anatomical signatures across disorders previ-
ously reported to be associated with psychopathological 
syndromes within 1 or 2 disorders.
We did not find associations between GMV and the 
depression factor, a finding in line with the vast majority 
of previous studies.45,46,80 Structural alterations in patients 
with MDD are not correlated with current depressive 
symptomatology but rather chronicity and cumulative 
severity.45,47,81,82
Within the ROI analysis, the negative syndrome was 
associated with the bilateral frontal opercula volumes. 
This is a well-known finding from structural imaging 
studies investigating SZ patients.83–87 GMV reductions in 
the frontal opercula correlated with persistent negative 
symptoms.37,83,88
Table 3. Significant Gray Matter Volume Reductions in the ROIs, FWE Peak-Level Corrected
Factor ROI Coordinates
P  
FWE k T Z
Negative syndrome (F2) Bilateral frontal opercula [−48; 18; 21] .031 21 3.512 3.501
Positive formal thought disorder (F3) Left amygdala-hippocampus complex [−34.5; −22.5; −15] .018 99 3.386 3.376
Paranoid-hallucinatory syndrome (F4) Bilateral thalami proper [−6; −12; 12] .006a   
1201
3.995 3.979
[−13.5; −25.5; 10.5] .007 3.943 3.928
[9; −3; 1.5] .013 3.760 3.747
Left angular gyrus [−55.5; −64.5; 27] .026 15 3.627 3.615
Left postcentral gyrus [−61.5; −19.5; 31.5] .003a   
405
4.267 4.248
[−58.5; −21; 39] .005a 4.172 4.154
[−57; −22.5; 25.5] .007 4.076 4.059
Left posterior cingulate gyrus [−13.5; −40.5; 3] .011 11 3.633 3.621
Note: FWE, family-wise error; ROI, region of interest. ROIs tested are listed in table 2.
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The pFTD factor was negatively associated with the 
right MFG on whole brain level, and the left amygdala-
hippocampus complex in the ROI analysis. Previously, 
pFTD in SZ has been associated with neuroanatomical 
alterations in Wernicke’s and Broca’s language areas, as 
well as the middle frontal gyri and the left amygdala-
hippocampus complex.32–35 We could replicate these find-
ings in our transdiagnostic sample. As opposed to the 
left, we found the right MFG homologue associated with 
pFTD, an area which is involved in language processing 
in SZ patients.32,34,35 Furthermore, there is evidence that 
the hippocampus plays a major role in word generation 
tasks which coincides with our findings.89,90
On a whole brain level, the paranoid-hallucinatory 
syndrome was negatively associated with the right fusi-
form gyrus and the left MFG. Previous studies24,25,27,31,40,91 
showed that medial temporal regions are correlated with 
“positive” symptomatology, which mainly comprises the 
paranoid-hallucinatory syndrome. Besides the inferior 
temporal gyri, the bilateral fusiform gyri have been re-
ported as a significant correlate of positive symptoms 
(measured with Positive and Negative Syndrome Scale 
[PANSS]).40,91 A meta-analysis including 4474 paranoid-
hallucinatory SZ patients showed that reductions in both 
the right fusiform gyrus and the bilateral inferior tem-
poral gyri have the largest effect sizes.92 Several studies 
have shown negative associations of GMV and the 
paranoid-hallucinatory syndrome factor in the overall 
frontal volume93 as well as GMV reductions in the left 
pars orbitalis and the left superior frontal gyrus.40 The 
left MFG has been shown to be deactivated in preceding 
auditory hallucinations.94 The ROI analyses revealed sig-
nificant associations between the paranoid-hallucinatory 
syndrome and the bilateral thalami proper,27,28,95 the left 
angular gyrus, the postcentral gyrus, and the left posterior 
cingulate gyrus,25,27 confirming many previous studies.
The factor “increased appetite” was, independent of 
medication, a dimension in our psychopathological factor 
analytic study2 that has been shown to emerge if  psycho-
pathological scales are used that capture vegetative symp-
toms.48,96 We did not find associations with GMV neither 
on whole brain level nor within the ROI analyses. This 
may indicate that biological influences other than GMV 
have an impact on the manifestation of increased appetite. 
Nevertheless, increased appetite is a relevant syndrome 
across disorders that deserves further investigation.
Limitations
Some limitations must be noted. First, patient groups 
were unequally distributed which potentially biased our 
results since the MDD group was the largest. However, 
we were able to confirm the results of our interaction ana-
lyses (total sample) in an age- and sex-matched subsample 
(same n in each diagnosis). Second, the MDD group only 
marginally presented with psychotic symptoms compared 
to BD and SSD patients resulting in restricted variance 
found for psychotic symptoms (ie, factor 4  “paranoid-
hallucinatory syndrome”). Third, the extracted factors 
were based on current psychopathology. Correlating 
current state measures with brain structure misses past 
psychopathology. However, specific current symptoms 
are an indication for a particular neuroanatomical, state-
independent alteration that outlasts current symptoms. 
Still, it would be of great interest to investigate the sta-
bility of both factor dimensions and their relationship to 
brain structure validating the present cross-sectional re-
sults. Fourth, pharmacological treatment was considered 
in our models using 3 dummy-coded variables accounting 
for the intake of antidepressants, mood stabilizers, and 
antipsychotics. However, the influence of both dosage 
and duration of intake on GMV is not considered.
Conclusion
In sum, our findings provide a novel anatomical mapping of 
psychopathological symptom dimensions across disorders. 
The main strength of the present study is the use of a large 
transdiagnostic cohort, innovative data-driven psychopath-
ological factors, and the inclusion of patients across psy-
chotic and affective disorders. Our findings give evidence 
for shared and diagnosis-independent GMV reductions 
associated with symptom dimensions. We try to overcome 
a current deadlock in scientific approaches which has one 
origin in a misguided reification of DSM diagnoses.
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There is a lack of knowledge regarding the relationship between dimensional 
psychopathological syndromes and neurocognitive functions, particularly across the 
major psychiatric disorders (i.e., Major Depressive Disorder (MDD), Bipolar Disorder 
(BD), and Schizophrenia (SZ)).  
Method:  
SANS, SAPS, HAMA, HAM-D, and YMRS were assessed in 1,064 patients meeting 
DSM-IV criteria for MDD, BD, SZ or schizoaffective disorder (SZA). In addition, a 
comprehensive neuropsychological test battery was administered. Psychopathological 
syndromes derived from factor analysis and present state of illness were used to explore 
psychopathology-cognition relationships. Correlational analyses were corrected for age, 
sex, verbal IQ, years of education, and DSM-IV diagnosis. Age of onset and total duration 
of hospitalizations as proxies for illness severity were tested as moderators on the 
cognition – psychopathology relationship. 
Results: 
The negative syndrome, positive formal thought disorder as well as the paranoid-
hallucinatory syndrome exhibited associations with neuro-cognition in an illness state-
dependent manner, while the psychopathological factors depression and increased 
appetite only showed weak associations. Illness severity showed moderating effects on 
the neurocognitive-psychopathology relationship only for the negative syndrome and 
positive formal thought disorder.  
Conclusions: 
This study suggests the relationship of neuro-cognition and psychopathology to be highly 
state of illness-dependent across affective and psychotic disorders. Results hint at the 
moderating effects of illness severity on psychopathological factors that might be more 
treatment resistant. 
Keywords 





More than a century of research on the neurobiological underpinnings of 
psychotic (schizophrenia, SZ; schizoaffective disorder, SZA) and affective disorders 
(Major Depressive Disorder, MDD; Bipolar Disorder, BD) - collectively referred to as 
major psychiatric disorders - has been unable to identify transdiagnostic markers within 
the major psychiatric disorders. There is evidence that the major psychiatric disorders 
share familial and molecular genetic risk [1, 2], environmental factors [3], and changes 
in brain structure [4, 5]. Even though these overlaps have been well documented, there 
is a lack of studies investigating the relationship between psychopathology and 
neuropsychological functioning in transdiagnostic samples, especially taking current 
state and course of the illness into account.  
 
1.1 Factor models of psychopathological symptoms across diagnoses 
In light of the challenges given by categorical approaches comparing disorders 
to a healthy control group not considering the overlaps between disorders, dimensional 
approaches have been increasingly performed [6, 7]. However, most studies focused on 
psychopathological factors being prominent in the diagnostic category investigated (i.e. 
psychotic symptoms in SZ) or were restricted to one or two diagnostic groups only using 
one psychopathological scale, not covering a wide range of symptomatology. 
Investigating a transdiagnostic samples Reininghaus et al. showed 3 to 5 factor solutions 
[8]. Previously, a meta-analysis of five studies including SZ, MDD, BD, and anxiety 
patients measuring psychopathology with the PANSS or BPRS revealed five factors: 
affective, positive, negative, disorganized, and cognitive processing [9]. Investigation of 
six lifetime psychopathological factor models in SZ patients, patients with delusional 
disorder and BD (all diagnosed with DSM-IV) revealed that 4- or 5 factor models better 
describe symptomatology than models with less factors [10]. Recently, we identified and 
confirmed a five-factor model in a sample comprising of more than 1,100 patients with 
MDD, BD, SZ or SZA [11]. The extracted factors were depression, negative syndrome, 
positive formal thought disorder (pFTD), paranoid-hallucinatory syndrome and increased 
appetite. All five factors were present in all patients supporting the view of overlapping 
phenomenology [11] as well as shared neuro-anatomy [12] across disorders.  
 
1.2 Neuropsychological impairments in major psychiatric disorders 
Meta-analyses in MDD showed that depending on the domain tested, patients’ 
impairments have small to medium effect sizes. However, there was no clear-cut 
difference between current depression or remission [13] regarding their 
neuropsychological performance. In another meta-analysis, small effect sizes could still 
66 
 
be observed even when comparing healthy controls (HC) to euthymic MDD. However, it 
could be shown that the course or onset of the disorder affects cognition as late-onset 
depression was associated with more pronounced cognitive impairment [14]. The reason 
for the discrepancy in these findings may be explained by a recent study that showed 
gray matter volume in areas critical for cognitive performance such as the hippocampus 
is affected by illness severity rather than by current psychopathology [15]. Thus, 
cognitive performance depending on these structures such as episodic memory [16] 
might be better explained by illness severity rather than by acute psychopathology.  
In BD, even in euthymic phases, meta-analytical findings point to impairments in 
almost all domains tested [17]. Largest effect sizes are found in executive functioning 
and working memory and impairments in executive functioning might be indicative of a 
poor clinical course of the disorder. Possible moderators of these impairments include 
level of education, age, and duration of illness [17]. 
In SZ, early meta-analyses already pointed to impairments in all domains 
reported [18]. Largest effect sizes were reported for verbal memory, motor skills and 
executive functioning. However, other meta-analyses suggested that processing speed 
impairments could be an underlying deficit partly explaining impairments in other 
domains [19]. More recently, it could be demonstrated that neuropsychological test 
performance remains relatively stable [20] while psychopathology may vary to some 
degree during the course of the disorder.  
Recently, in a study investigating cognition in MDD, BD and SZ it could be found 
that all three patient groups differed from HC [21]. Within this study, differences between 
patient groups and HC emerged for all domains. However, “executive functioning” was 
the only domain showing differences between SZ and HC, while MDD and BD did not 
differ significantly. The only domain however, that exhibited differences between all 
groups investigated was “motor Speed”, with the SZ had the poorest performance and 
MDD and BD were located between SZ and HC. For several cognitive domains, 
differences in performance do not differ between BD and SZ in the majority of studies. 
This is in particular true when the groups compared also include patients with SZA and/or 
BD with psychotic features [22]. Because of these results, characteristics different from 
diagnosis per se might better differentiate between patient groups like global (cognitive) 
functioning [23]. 
 
1.3 Neuropsychological performance, psychopathology, course and state of 
illness 
To date, only few studies are available describing the relationship of current 
psychopathology and neurocognitive functioning in transdiagnostic samples consisting 
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of more than two patient groups. However, several studies comparing SZ and BD have 
been conducted showing that cognitive performance is potentially related to a number of 
factors [22] which are not restricted to current psychopathology: Own or parental level of 
education and number of hospitalizations could potentially influence cognition, 
depending on diagnosis and cognitive domain studied. 
In a transdiagnostic sample (MDD, BD and SZ), objectively observable rather 
than subjectively reported positive and negative symptoms of FTD were correlated with 
several cognitive domains [24]: pFTD had a significant negative association with 
executive functioning while negative FTD was negatively associated with different 
markers of verbal fluency and verbal working memory. The relationship of impaired 
executive functioning and pFTD was most pronounced in BD while negative formal 
thought and verbal fluency impairments were most pronounced in SZ and HC. 
In a study investigating SZ, siblings of patients, and HC, it was found that negative 
symptoms as well as disorganization symptoms showed correlations, especially with 
working memory and episodic memory [25] while there were no significant correlations 
between positive symptoms and neuropsychological test results. Recently, in a 
transdiagnostic sample, it was reported that only a negative/disorganized symptoms 
factor showed correlations with cognitive performance, while other factors such as 
affective symptoms did not [26]. 
Current severity and course of disorders have been found to play an important 
role in cognition and cognitive performance: In acutely depressed patients, impairments 
in a variety of domains such as working memory have been described while this 
relationship was not found in remitted patients [27]. Similar results were found in BD and 
SZ [28]: Acuity of psychotic symptoms was associated with greater cognitive 
impairments. SZ with acute symptoms was additionally associated with greater 
impairments in processing speed. But there is not only a relationship of symptoms and 
cognitive impairments in major psychiatric disorders, these impairments have been 
demonstrated to have predictive value: Impairments in verbal memory have been shown 
to predict conversion to first-episode schizophrenia in clinical high-risk individuals [29].  
Based on the studies outlined above, several open questions were to be 
addressed in the present study: 1. Based on own recent factor-analytical findings, current 
psychopathology was to be correlated with neuropsychological performance across 
affective and psychotic disorders. Hereof, we hypothesized correlations between 
negative and FTD symptoms and cognitive performance, while weaker or no correlations 
with affective (depression) and positive symptoms (paranoid-hallucinatory symptoms) 
were expected. 2. Since previous studies reported cognitive performance to be highly 
influenced by the current state of disorder, we further assessed the relationship between 
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neuro-cognition and psychopathology factors in a current state of illness dependent 
manner. Therefore, remission and disease course cut-offs based on psychopathological 
measures were used rather than DSM criteria as there is no coding for the course of 
psychotic disorders implemented in the DSM. 3. Lifetime total duration of hospitalizations 
and age of disorder onset were used as illness severity proxies and were tested for 
moderating effects on the neuro-cognition – psychopathology associations. Total 
duration of hospitalizations were expected to positively predict neuro-cognition – 
psychopathology associations (i.e. magnify neuro-cognition – psychopathology 
associations) while for age of disorder onset negative moderation effects were 
hypothesized.  
   
2. Material and methods 
2.1 Participants 
Participants were part of the FOR2107 cohort [30]. Psychopathological scales 
and neurocognitive tests were administered at the Departments of Psychiatry and 
Psychotherapy in Marburg or Münster, Germany. Participants were recruited via 
inpatient facilities of the University Hospitals and from the departments of participating 
local hospitals. Outpatients were recruited via flyers and postings in newspaper. To be 
included in the present study verbal IQ had to be > 80, patients had to be free of serious 
medical illnesses (cancer, autoimmune diseases), neurological illness, and current 
substance dependence. Furthermore, we had to exclude n=118 patients from the original 
study [11] due to incomplete neuropsychological data resulting in N= 1,064 patients 
(aged 18-65) meeting DSM-IV criteria for MDD (n=821, f=535/m=286), BD (n=130, 
f=65/m=65), and SZ/SZA (n=113, f=52/m=61)) (see Table 1) for the present study. At 
time of assessment n=330 patients were in inpatient care (n=247 MDD, n=36 BD, n=47 
SSD). The local ethics committees approved the study protocol. Patients gave written 
informed consent to the study protocol. 
 
2.2 Psychopathological assessment and factor score calculation 
The complete procedure has been reported in [11]. In short, the following scales 
with a total of 104 symptoms were administered during a clinical interview (including 
SCID-I): the SANS and the SAPS [31, 32], HAMA [33], HAM-D [34], and the YMRS [35]. 
Psychopathological scales were rated by trained interviewers achieving good inter-rater 
reliability (>.86 in all scales). Following the procedure described in [11], we performed a 
cross-validation approach using varimax rotated explorative and confirmatory factor 
analyses in two samples. Results revealed a 5-factor model comprising: F1: Depression, 
F2: Negative Syndrome, F3: Positive Formal Thought Disorder, F4: Paranoid-
Hallucinatory Syndrome and F5: Increased Appetite. For the present study, we used the 
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latent factor scores for each patient and factor of our previous analyses for further 
calculations. 
 
2.3 Neuropsychological assessment 
The following tests were administered in all subjects: The d2 test of attention [36], 
verbal fluency [37], symbol-coding [38], spatial span [39], letter-number span [40], Trail-
Making Test A and B (TMT) [41], and the German Verbal Learning and Memory Test 
(VLMT) [42]. Verbal IQ was assessed with the multiple choice vocabulary test (MWT) 
estimating premorbid intelligence [43]. Taken together, these tests assess performance 
in the domains of attention (d2), executive functioning (symbol-coding, verbal fluency, 
TMT), verbal and visuo-spatial working memory (letter-number span and spatial span), 
verbal learning (VLMT) as well as verbal episodic memory, retrieval and recognition 
(VLMT). In the case of verbal fluency, semantic verbal fluency (“sem. VF”; category 
“animals”), lexical verbal fluency (“lex. VF”; starting letter “p”) and category switching 
(“cat. VF”; alternating between sports/fruit) were assessed for one minute each. For 
further calculations, the sum of backward and forward processing of the spatial span 
were summarized and results of the TMT part A were subtracted from part B.  
 
2.4 Statistical Analyses 
Descriptive statistics are summarized in Table 1. To investigate our first 
hypothesis, we performed, partial correlation analyses for neuropsychological results 
and latent factor scores of the five factors in the total sample (N=1,064). Within this 
procedure, age, sex, years of education, and verbal IQ were controlled for (see Table 2). 
Verbal IQ and years of education were correlated (p<0.0001, r=0.352) but 
multicollinearity for these two variables was absent (tolerance=1.0, VIF=1.0). To rule out 
potential effects of DSM-IV diagnostic categories, we added a three steps DSM-IV 
diagnosis variable to our correlational model.  
Following our second assumption of state of illness dependent associations 
between neuro-cognition and psychopathology, the same partial correlation analyses 
were performed for subgroups based on clinical status. Since remission criteria for 
affective but not for psychotic disorders are implemented in the DSM-IV, the clinical 
status was defined based on published remission cut-offs for the used scales [44–47]. 
The clinical course was defined using item 90 of the OPCRIT 4 (“course of disorder” 
[48]). Based on information drawn by the semi-structural interview and hospital records, 
item 90 of the OPCRIT assesses the following courses: single episode with remission, 
multiple episodes with remission between episodes, multiple episodes with partly 
remission between episodes, chronic course, and persistent chronic course. 
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Subsequently, both the information on the clinical status (acute psychopathology rating 
scales) and the information on the course of disorder (OPCRIT item 90) were combined 
dividing the patients of the present study into three groups. An “acute patient with a 
chronic course” was defined when exceeding one of the following cutoffs: SANS global 
ratings (items 7 “affective flattening”, 12 “Alogia”, 16 “Avolition-apathy”, and 21 
“Anhedonia-asociality”) >2 [44], or SAPS global ratings (items 7 “Hallucinations”, 20 
“Delusions”, 25 “Bizarre behavior”, 34 “Positive formal thought disorder) >2 [44], or 
HAMA sum score >19 [45], or HAM-D sum score (17 item version) >6 [47], or YMRS 
sum score >4 [46], and when item 90 of the OPCRIT 4 was >2 (i.e. chronic or persistent 
chronic course). The second group “acute patients with full remission between episodes” 
was defined like the first group except for item 90 of the OPCRIT 4 (scoring ≤2, i.e. single 
episode with remission or multiple episodes with remission or partly remission). The third 
group “remitted patients” did not exceed any of the above cutoffs at the time of 
psychopathological assessment. All partial correlations were corrected per table for 
multiple testing using the false discovery rate (FDR) [49] and two-tailed p-values were 
used in all analyses.  
Since sample sizes across the three clinical course groups differed, we performed 
power analyses (G Power, version 3.1.9.7) [50] to estimate the sample size needed to 
detect significant correlations. Therefore non-significant correlation coefficients of the 
three clinical subgroups that were previously significant in the total sample were used. 
Power was set at 0.8 and significance at p<.05.  
Finally, we were interested in moderating effects of clinical variables (i.e. lifetime 
total duration of hospitalizations, age of disorder onset). Therefore, we used moderator 
models (PROCESS macro v3.3 for SPSS, model number 1) that were corrected for the 
same covariates as correlational analyses. Moderator models were only performed for 
significant correlations between neuro-cognition and psychopathology as presented in 
Table 2. To account for multiple testing moderation results were corrected per moderator 
using FDR correction.  
 
3. Results 
Table 1 describes the sociodemographic and clinical characteristics of the participants, 
results of the partial correlation analyses are described in Table 2. Analyses based on 






Table 1  































13.12 (2.7) 13.73 (2.78) 12.28 (2.65) 
p= 0.017b 
(4.07) 
Age of Onset 26.04 (12.72) 24.82 (11.47) 22.28 (9.18) 
p= 0.006c 
(5.13) 






























-0.01 (0.52) 0.02 (0.59) -0.09 (0.34) 
p= .23 
(1.47) 
D2 (KL) 168.04 (42.18) 158.92 (46.18) 139 (42.85) 
p< 0.0001b 
(17.47) 
sem. VF 23.15 (5.79) 21.8 (6.03) 20.52 (5.05) 
p= 0.001c 
(7.54) 
lex. VF 11.14 (4.11) 11.15 (4.82) 9.6 (4.36) 
p= 0.023b 
(3.8) 











































112.65 (13.69) 114.86 (14.6) 111.8 (14.62) 
p= 0.171  
(1.77) 
Values indicate means of total values and standard deviations (SD) (in brackets). Post 
hoc differences between groups: a= MDD < BD. b= SZ < MDD, BD. c= SZ < MDD. d= 
MDD > SZ, BD. e= SZ > MDD, BD. f= SZ > MDD, BD; BD> MDD. g= SZ < MDD, BD; BD 
< MDD. h= MDD > SZ, BD; BD > SZ. i= MDD < BD, SZ. 
 
Table 2 
Partial Correlation Analyses of Neuropsychology and Psychopathology (whole sample, 


















D2 (KL) -0.046 -0.085** -0.1*** -0.04 -0.014 
Sem. VF -0.049 -0.055 -0.004 0.000 -0.068*  
Lex. VF -0.056 -0.067*  -0.007 0.017 -0.046 
Cat. VF -0.086**  -0.124***  -0.084** -0.07* -0.075* 
Symbol-
Coding 
-0.08**  -0.106***  -0.059 -0.029 -0.02 
Spatial 
Span (total) 




-0.057 -0.108*** -0.083** -0.019 0.019 
TMT 
(difference) 




-0.024 -0.089** -0.004 -0.067*  0.018 
 VLMT (loss 
delayed 
recall) 




-0.045 -0.098*** -0.103*** -0.067*  -0.023 
Age, sex, verbal IQ, years of education and DSM-IV coded diagnoses were controlled 
for. Bold letters indicate significant correlation coefficients (r) after FDR correction for 
multiple testing. *p≤.05; **p≤ .01; ***p≤ .001, italics indicate significant results without 









Partial Correlation Analyses of Neuropsychology and Psychopathology in acute patients 


















D2 (KL) 0.036 0.073 -0.150 -0.095 -0.052 
Sem. VF -0.017 -0.065 0.064 0.077 -0.108 
Lex. VF -0.052 -0.044 0.084 0.074 -0.062 
Cat. VF -0.002 -0.129 -0.103 -0.06 -0.007 
Symbol-
Coding 
-0.068 -0.011 -0.054 -0.045 -0.048 
Spatial 
Span (total) 




-0.057 0.005 -0.128 0.074 0.03 
TMT 
(difference) 








0.038 0.059 0.227** 0.263**  0.057 
Recognition 
(VLMT) 
-0.05 -0.004 -0.14 -0.052 -0.048 
Age, sex, verbal IQ, years of education and DSM-IV coded diagnoses were controlled 
for. Bold letters indicate significant correlation coefficients (r) after FDR correction for 
multiple testing. *p≤.05; **p≤ .01; ***p≤ .001, italics indicate significant results without 







Partial Correlation Analyses of Neuropsychology and Psychopathology in acute patients 


















D2 (KL) -0.073 -0.136** -0.107** -0.033 0.045 
Sem. VF -0.04 -0.068 -0.023 -0.029 -0.036 
Lex. VF -0.067 -0.1* -0.011 0.015 0.011 
Cat. VF -0.086 -0.097*  -0.086* -0.076 -0.081 
Symbol-
Coding 
-0.023 -0.121** -0.046 0.015 0.047 
Spatial 
Span (total) 




-0.031 -0.143*** -0.075 -0.028 0.062 
TMT 
(difference) 








-0.065 0.087 0.024 0.024 0.008 
Recognition 
(VLMT) 
0.007 -0.134** -0.108** -0.071 0.007 
Age, sex, verbal IQ, years of education and DSM-IV coded diagnoses were controlled 
for. Bold letters indicate significant correlation coefficients (r) after FDR correction for 
multiple testing. *p≤.05; **p≤ .01; ***p≤ .001, italics indicate significant results without 





















Partial Correlation Analyses of Neuropsychology and Psychopathology in remitted 


















D2 (KL) -0.021 -0.118*  -0.084 -0.052 -0.096 
Sem. VF -0.04 -0.005 -0.001 0.011 -0.095 
Lex. VF 0.005 -0.001 -0.043 -0.026 -0.13* 
Cat. VF -0.04 -0.123* -0.104* -0.133** -0.085 
Symbol-
Coding 
0.066 -0.029 -0.048 -0.007 -0.074 
Spatial 
Span (total) 




0.028 -0.091 -0.056 -0.096 -0.034 
TMT 
(difference) 








-0.024 0.054 0.055 0.08 -0.01 
Recognition 
(VLMT) 
0.005 -0.014 0.059 -0.044 -0.028 
Age, sex, verbal IQ, years of education and DSM-IV coded diagnoses were controlled 
for. Bold letters indicate significant correlation coefficients (r) after FDR correction for 
multiple testing. *p≤.05; **p≤ .01; ***p≤ .001, italics indicate significant results without 
correction for multiple testing.  
 
Associations in the three sub-samples were differential compared to those of the 
total sample, unsurprisingly as sample sizes across the three clinical course groups 
differed which might have resulted in restricted power. To address this, we performed 
power analyses estimating the sample size needed to detect significant correlations. 
Depending on the neuro-cognitive test at least n=367 (association of the negative 
syndrome and categorical VF, see Table 3a) acute patients with a chronic course would 
be needed to detect significant associations. For acute patients with remission during 
episodes at least n=832 patients (association of depression and categorical VF, see 
Table 3b) and for remitted patients at least n=1796 patients (association for depression 
and symbol coding, see Table 3c) would be needed to identify significant correlations of 
psychopathology and neuro-cognition.  
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Moderator analyses showed the following moderating effects of the clinical 
variables tested (see also Figure 1 and 2): the total duration of hospitalizations positively 
moderated the associations of the Negative Syndrome with executive functioning 
(symbol coding) (total model: R2=32.81%, F(8,1019)=62.19, p<0.001, moderation effect: 
b=0.04, F(8,1019)=5.66, p=0.018), and attention (total model: R2=32.93%, 
F(8,1019)=62.53, p<0.001, moderation effect: b=0.13, F(8,1019)=4.43, p=0.035), while 
the age of onset negatively moderated the associations of the Negative Syndrome with 
executive functioning (TMT difference) (total model: R2=17.66%, F(8,1047)=28.07, 
p<0.001, moderation effect: b=-0.17, F(8,1047)=3.92, p=0.048) and verbal episodic 
memory (total model: R2=18.91%, F(8,1047)=30.52, p<0.001, moderation effect: b=-
0.03, F(8,1047)=4.77, p=0.029). Total duration of hospitalization positively moderated 
the association of pFTD and verbal episodic memory (total model: R2=18.37%, 
F(8,1019)=28.67, p<0.001, moderation effect: b=0.03, F(8,1019)=5.35, p=0.037). The 
association of pFTD and verbal episodic memory was negatively moderated by the age 
of onset (total model: R2=18.98%, F(8,1047)=30.67, p<0.001, moderation effect: b=-0.1 
F(8,1047)=5, p=0.026). However, when correcting for multiple testing (FDR) no 
moderation effect was present for both the lifetime duration of hospitalizations and age 























Moderation effects of total duration of hospitalization and age of onset on the 
associations of the Negative Syndrome (F2) and neuro-cognition (models were corrected 




Moderation effects of total duration of hospitalization and age of onset on the 
associations of the Positive Formal Thought Disorder (F3) and neuro-cognition (models 








In the present study, correlations of neuropsychological test scores and current 
psychopathological syndromes were examined. Of note, when studying the results, if no 
such significant correlation can be detected, this does not mean that symptoms or 
potential cognitive deficits are absent, rather, their respective values do not correlate 
during the time of investigation. Furthermore, clinical variables (i.e. lifetime total duration 
of hospitalizations, age of onset) were tested for moderating effects on the 
psychopathology – neuro-cognition associations.  
The main findings can be summarized as follows: 
1. According to the results of the neuropsychological testing, patients with SZ 
performed worse than both other groups and patients with BD scoring mostly in between 
patients with MDD and SZ.  
2. Independent of diagnosis and current state of disorder, the three factors 
Negative Syndrome, pFTD and Paranoid-Hallucinatory Syndrome showed largest 
correlation coefficients. However, depending on the current state of the disorder, different 
correlation patterns emerged (see below). In contrast, Depression and Increased 
Appetite rarely showed significant correlations. 
3. For the two factors Negative Syndrome and pFTD, state-dependent 
correlations with neuropsychological test results emerged: In remitted patients, 
neuropsychological test results were not correlated with any of the psychopathological 
factors after correction for multiple testing. In acute patients with full remission between 
episodes, correlations were found for the Negative Syndrome and pFTD while in acute 
patients with a chronic course, correlations were found for the pFTD and Paranoid-
Hallucinatory syndrome. In previous meta-analyses, it has been found that a potential 
correlation between negative and/or disorganization symptoms and executive 
functioning is found in chronic courses of SZ while in first-episode SZ, these relationships 
are either weaker or absent [51]. However, this is not necessarily true for the other 
disorders studied here. 
4. Lifetime total duration of hospitalizations and age of onset were used as 
proxies for illness severity and tested for moderating effects on the psychopathology – 
neuro-cognition associations. While the total duration of hospitalizations enhanced the 
associations between the neuro-cognitive performance and the factors Negative 
Syndrome and FTD, the moderator age of disorder had the opposite effect (i.e. negative 
moderation). However, after applying corrections for multiple testing no moderation 
effects were present. 
Upon closer inspection of the individual factors, several additional results deserve 
discussion. When interpreting state of illness-dependent associations two limiting factors 
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should be considered. First, the range of symptoms might by truncated in each of the 
state of illness subgroups. Depending on the state of illness and diagnostic group 
variance of psychopathological symptoms might be restricted resulting in a lack of 
correlations detected. This would explain the absence of psychopathology – neuro-
cognition associations in remitted patients. While neuro-cognitive impairment [20] is 
reported to be stable over time, psychopathological symptoms vary. There is meta-
analytical evidence that cognitive remediation therapy might result in an improvement of 
cognition, while effects on psychopathology are limited [52, 53]. Based on current 
findings, it could be argued that during remission, these trainings might be most effective 
as current psychopathology is less pronounced and thus should not interfere as much 
with training sessions. Second, the absence of correlations reported in the total sample 
in the three subgroups might be explained by different sample sizes and therefore less 
statistical power across analyses. Depending on the cognitive domain and state of 
illness, samples sizes of at least 367 to 1796 patients would be needed to detect 
significant associations.  
Large differences between states of disorder types occurred for the factor 
Paranoid-Hallucinatory Syndrome. Patients with a chronic course of their respective 
disorder displayed an association between the current psychopathology and verbal 
episodic memory. This relationship was completely absent in patients in full remission 
and in patients with an acute episode and full remission between episodes which might 
be explained by the treatment response to antipsychotic medication [54, 55]. 
The association of pFTD and neuro-cognition seems to follow a comparable 
trend: While patients with a chronic course show a correlation with verbal episodic 
memory, acute patients with full remission between episodes show a correlation with 
executive functioning. No associations were present in patients in current remission.  
The Depression factor did not show any association with cognitive performance 
in different illness states. In the total sample, Depression was correlated with verbal 
fluency (categorical task) and executive functioning. This finding is in line with previous 
findings in large transdiagnostic samples [26]. Given that this factor is mainly driven by 
MDD patients, it has been shown that cognitive impairments also tend to remit after 
symptom remission [13] so that a correlation in acute patients is the most probable.  
The Negative Syndrome was correlated with cognitive performance in a number 
of domains which is consistent with previous reports [25, 26]. This relationship is most 
pronounced in the total sample. However, when considering the different stages and 
courses of disorder, this relationship is only strong in acute patients with full remission 
between episodes. This could be explained by the heterogeneity of the course of 
negative symptoms while neuro-cognition remains stable or vice versa. A full remission 
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between episodes hints at the improvement of negative syndromes across all diagnoses, 
although they remain relatively stable in SZ while positive symptoms show a larger 
amount of improvement over time in all groups [56].  
Finally, when considering cognitive domains rather than psychopathology, it 
becomes clear that all domains show associations with psychopathology, though to 
different degrees depending on the state of illness. In VF, category fluency (switching) is 
the most consistently associated test with psychopathology, most likely because it is the 
most demanding of the VF tests. Other domains, such as executive functioning (symbol-
coding and TMT) and working memory (spatial span and letter-number-span) also show 
high levels of consistency in their association across syndromes and states. It is 
somewhat surprising that verbal episodic memory does only rarely show associations 
with current psychopathology. Given that verbal memory is often found to be impaired in 
MDD even in an euthymic state [14] and it is the most severely impaired domain in SZ, 
these relationships warrant additional clarification in future research. 
Further analyses of moderators on the neuro-cognition – psychopathology 
relationship revealed that total duration of hospitalizations as well as age of onset did 
indeed moderate correlations with the Negative Syndrome and pFTD, but not the other 
factors in the total sample. While the total duration of illness positively moderated 
associations between neuro-cognition and psychopathology (i.e. more duration of 
hospitalization predicts the relationship between neuro-cognition and psychopathology 
to be stronger), age of onset weakens the associations between neuro-cognition and 
psychopathology. Previously, a meta-analyses [57] of age of onset and cognition in SZ 
patients reported individuals with youth-onset having severe cognitive deficits while 
patients with late-onset revealed somehow retained cognitive functioning. In a 
longitudinal study [58], illness severity has been negatively associated with neuro-
cognition (i.e. verbal learning and working memory) in SZ patients pointing to a 
significantly better neuro-cognitive performance when patients spent less time 
hospitalized during follow-up. This is in line with the present study showing a moderating 
effect of total duration of hospitalizations (lifetime) since patients spending more time in 
hospital also showed worse cognitive performance being associated with higher load on 
psychopathological factors. Additionally, the absence of moderating effects regarding the 
neuro-cognition and Paranoid-Hallucinatory Syndrome associations might be explained 
by being more responsive to antipsychotic medication than negative syndromes [54, 55]. 
In the light of current results, pFTD thus might be also more persistent than paranoid-
hallucinary symptoms [20, 59]. As such, one might argue that illness severity (onset and 
duration of hospitalizations) should impact more on uncontrollable factors. As 
Depression only showed few significant correlations with neuro-cognition, the absence 
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of moderating influence of illness severity was to be expected. Comparable to the 
Paranoid-Hallucinatory Syndrome, the absence of moderating effects might hint at the 
possibility that depressive symptoms could be less stable over time and might show a 
higher degree of remission and are thus less influenced by illness severity. Overall, it 
appears that for the Negative Syndrome as well as pFTD, illness severity impacts on the 
neuro-cognition – psychopathology relationship, albeit these results did not survive 
correction for multiple testing.  
 
5. Limitations 
The MDD group is the largest representing the prevalence of the investigated 
disorders in the population. Since we hypothesized that there are no “points of rarity”, 
equal sizes of diagnostic categories might discount our approach. Moreover, we wanted 
to investigate syndrome-cognition associations dimensionally and not within categorical 
diagnoses.  
On a methodical level, it has to be noted that a high number of tests was 
performed due to the number of psychopathological factors, neurocognitive tests and 
state of illness. Even though after correction for multiple testing table-wise, some of these 
correlations could be considered false-positives. Some of these associations appear to 
have small effects only and reach significance due to sample size.  
Another limitation is that no healthy control subjects (HC) were entered into the 
analyses because of lack of variance in psychopathological symptoms. The lack of HC 
in the present study prevents us from drawing conclusions regarding the relative level of 
potential cognitive impairments. However, this was not the scope of this investigation as 
correlations between psychopathology and neuro-cognition were of main interest. When 
interpreting the results, sample characteristics have to be considered: The sample had 
a mean history of their respective disorder ranging from about 10.5 years (MDD) to about 
18 years (BD). Thus, factors such as years of medication intake could potentially 
influence the present associations. 
Finally, a cross-sectional design was employed. It would be of great interest to 
assess course of illness, current psychopathology as well as neuro-cognition in a 
longitudinal design to validate the present results prospectively.  
 
6. Conclusion 
To the best of our knowledge this is the first study investigating the association 
of psychopathological dimensions and neuro-cognition using several validated scales 
and neurocognitive tests across psychotic and affective disorders in acute, chronic, and 
remitted states. Our findings give new evidence for a state-dependent association of 
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psychopathological symptoms and cognitive performance across the major psychiatric 
disorders. The results presented here may serve as an important starting point for future 
longitudinal transdiagnostic investigations regarding symptom-cognition associations as 
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Factorial dimensions and neurobiological underpinnings of formal thought disorders 
(FTD) have been extensively investigated in schizophrenia spectrum disorders (SSD). 
However, FTD are also highly prevalent in other disorders. Still there is a lack of 
knowledge about transdiagnostic, structural brain correlates of FTD.  
Method: 
In N=1,071 patients suffering from DSM-IV major depressive disorder, bipolar disorder, 
or SSD, we calculated a psychopathological factor model of FTD based on the SAPS 
and SANS scales. We tested the association of FTD dimensions with 3 T MRI measured 
gray matter volume (GMV) and DTI white matter fractional anisotropy (FA) using 
regression and interaction models in SPM12. We performed post hoc confirmatory 
analyses in diagnostically equally distributed, age- and sex-matched sub-samples to test 
whether results were driven by diagnostic categories.  
Results: 
Cross-validation (explorative and confirmatory) factor analyses revealed three 
psychopathological FTD factors: verbosity, emptiness and disorganization. The verbosity 
dimension was negatively correlated with a GMV cluster comprising parts of the middle 
occipital and angular gyri and positively with FA in the right posterior cingulum bundle 
and inferior longitudinal fascicle. Emptiness was negatively associated with left 
hippocampus and thalamus GMV. Disorganization was negatively associated with FA in 
bilateral anterior thalamic radiation, and positively with the hippocampal part of the right 
cingulum bundle. None of the gray or white matter associations interacted with diagnosis.  
Conclusion:  
Our results provide a refined mapping of FTD phenotype dimensions and 
neuroanatomical signatures, pointing to language associated gray and white matter 
structures that are involved in FTD domains, independent of DSM-IV disorder.  
 
Keywords: formal thought disorder, white matter, gray matter volume, transdiagnostic, 






Formal thought disorder (FTD) refers to a construct measuring deviant thinking, 
speech and communication (1). FTD has been extensively investigated in schizophrenia 
(SZ), and schizoaffective disorder (SZA) (henceforth referred to as schizophrenia 
spectrum disorders, SSD), but much less in bipolar disorder (BD) and major depressive 
disorder (MDD) (all together henceforth referred to as major psychiatric disorders) (1,2). 
Prevalence rates of FTD range from 53% in MDD up to 80% in SZ (1). Patients with FTD 
have a higher risk for inpatient treatment, and they stay significantly longer in hospital 
(3).  
 Factor analyses of FTD symptomatology were previously performed in SZ 
patients. Only few studies investigated FTD dimensions across diagnosis showing 
common psychopathological dimensions (2,4–6). Depending on the scale and 
population, FTD can be broken down into one to six factors (2,7–9). Meta analyses (9,10) 
revealed two factors (i.e. positive and negative FTD). While there is consensus about 
one negative/poverty domain (11), positive FTD (pFTD) has been divided into two (e.g. 
disorganization, verbosity) to five (e.g. disorganization, idiosyncratic, semantic, 
attentional, referential) factors in SZ patients (8,9). pFTD symptoms are best represented 
by an increased amount of speech, tangentiality, derailment and circumstantiality (1). 
Negative FTD (nFTD) usually comprise a quantitative deficit resulting in poverty of 
speech, blocking and increased latency (2). 
Language production and processing is constituted by distributed cortical and 
subcortical networks (12). Altered brain structure in these language circuits might result 
in FTD. Diagnostically independent brain structural correlates of FTD symptoms would 
completely open up new approaches for pathogenic and etiological research. Similarly 
to FTD symptomatology, the neuroanatomical correlates of FTD have mainly been 
examined in SZ patients, but not in other diagnoses. Studies in SZ patients have shown 
that positive/disorganized FTD measured with the Positive and Negative Syndrome 
Scale (PANSS) (13), the Scale for the Assessment of Positive Symptoms (SAPS) pFTD 
subscale or the Scale for Thought, Language and Communication (TLC) (14) correlated 
negatively with the gray matter volumes (GMV) of the bilateral superior temporal gyri, 
inferior frontal gyri (IFG), the middle, medial and superior frontal gyri, the left amygdala-
hippocampus complex, the precuneus, the planum temporale, and the insula (15–17). 
nFTD have been negatively associated with GMV in the bilateral insula, the precuneus, 
the amygdala, the anterior and posterior cingulate gyri, and the medial 
frontal/orbitofrontal cortex (16,18). GMV associations with FTD across the major 
psychiatric disorders remain largely elusive.  
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The association of FTD dimensions and white matter diffusion tensor imaging 
(DTI) has been investigated to a much lesser extent than GMV in SZ and not at all in 
other diagnoses. Specifically in SZ patients a general dysconnectivity has been proposed 
(19). Moreover, one study indicated a structural language dysconnectivity in the semantic 
network which may be linked to FTD (20). Fiber tracts which have been associated with 
FTD are the inferior longitudinal fascicle (ILF), the left uncinate fascicle (21), the superior 
longitudinal fascicle (21), the inferior fronto-occipital fascicle (22), the cingulum bundle 
(CB) (23,24), and the anterior thalamic radiation (ATR) (22,24). There are no studies 
investigating white matter associations of FTD across the major psychiatric disorders, 
although FTD is common in all of these disorders.  
In order to provide significant progress for our understanding of FTD as a core 
psychiatric syndrome, both, phenotypes and brain correlates, must be untangled across 
diagnoses. This transdiagnostic endeavor is further driven by results showing large 
overlaps across MDD, BD, and SSD not only in symptomatology, but also in molecular 
genetic (25,26) and early environmental risk (27). Besides, it has long been 
hypothesized, but not yet scientifically confirmed, that a particular psychopathological 
symptom/syndrome (e.g. disorganization) has a common brain structural correlate 
across psychiatric disorders (28). In our study, we therefore used an explorative-
confirmatory cross-validation approach to disentangle the psychopathological factorial 
structure of FTD across MDD, BD and SSD. We associated the psychopathological 
factors with gray and white matter brain structure measured with MRI in a large patient 
sample (N=1,071). Based on previous findings (29), we hypothesized a factor model 
including one negative/emptiness factor, and additional positive domains (i.e. increased 
productivity and speech disorganization). Moreover, we hypothesized that the gray and 
white matter alterations previously associated with FTD in SZ patients (see above) are 




As part of the  FOR2107 cohort (for detailed information see (30)), a broad 
spectrum from acutely ill to remitted in- and outpatients from the departments of 
psychiatry,  university hospitals in Marburg and Münster, Germany and other psychiatric 
hospitals in their vicinity, were included in the study. All procedures were approved by 
the local Ethics Committees according to the Declaration of Helsinki and patients gave 
written informed consent to the study protocol.  
We excluded patients with IQ<80, history of head trauma or unconsciousness, 
current intake of benzodiazepines, and neurological illness from the present study. After 
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quality checks (as detailed below) of the T1 weighted scans and exclusion of patients 
with incomplete data, we analyzed 1,071 patients (aged 18-65) who met the criteria of 
the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) for 
MDD (n=821, f=536/m=285), BD (n=133, f=73/m=60), and SSD (n=117, f=57/m=60; SZA 
n=42, SZ n=75)) (see Table 1). For the DTI analyses we excluded additional n=241 
patients due to artifacts and caliber gaps, leaving a DTI sample of n=830 (MDD n=642, 
f=399/m=225; BD n=103, f=56/m=47; SSD n=103, f=50/m=53) (see supplement eTable 
3).  
 
Table 1: Descriptive statistics of the psychopathological factor analysis and voxel-based 

























13.21 (2.74) 14.06 (2.78) 12.52 (2.68) < .001b  
SANS alogia 
subscale 
0.49 (1.31) 0.62 (1.37) 1.83 (2.64) < .001c  
SAPS pFTD 
subscale 
0.36 (1.4) 1.71 (3.21) 3.13 (4.47) < .001d  
SANS sum  7.47 (8.65) 5.74 (7.33) 13.57 (12.4)  < .001c 
SAPS sum 0.66 (2.08) 2.37 (4.3) 10.03 (12.52) < .001d 
YMRS sum 1.43 (2.1) 3.89 (5.92) 2.69 (4.94) < .001d 
HAM-D sum 8.38 (6.4) 6.78 (5.82) 6.74 (5.79) .002e 
Note: Mean (standard deviation); TIV (= total intracranial volume); SANS (= scale for the 
assessment of negative symptoms (32)); SAPS (= scale for the assessment of positive 
symptoms (31)); YMRS (= Young mania rating scale (65)); HAM-D (=Hamilton rating 
scale for depression (66)). Tukey´s post hoc test was performed to investigate group 
differences. 
a MDD<BD 
b MDD<BD; SSD<BD 
c MDD<SSD; BD<SSD 
d MDD<BD,SSD; BD<SSD 
e SSD<MDD; BD<MDD 
 
Psychopathology assessment 
FTD symptoms were assessed during a clinical interview including the Structured 
Clinical Interview for DSM-IV axis I disorders (SCID-I) and psychopathology scales. 
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Ratings were conducted during or immediately after the interview. All interviewers were 
familiar and trained with evaluation of the psychopathological scales. Acute positive and 
negative symptoms were assessed with the scale for the assessment of positive 
symptoms (SAPS) (31) and the scale for the assessment of negative symptoms (SANS) 
(32). Interrater reliability was assessed with the interclass coefficient achieving good 
reliability of r>.86 in both scales. For the present analysis, we used the items of the alogia 
subscale of the SANS and the pFTD subscale items of the SAPS. Global alogia and 
pFTD rating items were not included in our analysis since they merely summarize single 
symptom ratings.  
 
FTD psychopathology factor analyses 
In a first step, we investigated the factorial structure of FTD symptoms in the VBM 
sample. To cross-validate FTD factorial dimensions in two sub-samples, we divided the 
total sample of N=1,071 using the “mindiff” package (33) in R (version 4.0.4) (34). To 
provide a comparable distribution of diagnostic categories in both samples, we split each diagnostic group separately 
accounting for age and sex as covariates, resulting in the explorative psychopathology sub-
sample 1 with n=537 (see supplement eTable1) and the confirmatory psychopathology 
sub-sample 2 with n=534 (see supplement eTable2).  
To investigate the explorative factorial structure of FTD, we performed a principal 
axis factor analysis (PFA) with varimax rotation of sub-sample 1 using the Statistical 
Package for Social Science (IMB, SPSS), version 25, Armonk, NY. Due to 
interpretability, items with factor loadings < 0.5 were not considered in the analysis (6). 
Cronbach's alpha coefficients (35) were used to test the internal consistency. 
To validate our explorative model, we performed a confirmatory factor analysis 
(CFA) using Mplus (version 8.4) (36) in the sub-sample 2. Additionally, we tested the 
confirmatory model for the whole sample (N=1,071). To rule out potential effects caused 
by the unequal distribution of DSM-IV diagnostic categories, we tested the model again 
in a smaller subsample with the same number of patients from each diagnosis, matched 
for age-and sex (see supplement eTable4, eTable5). Matching of the subsamples was 
performed using the “MatchIt” package (37) in R (34). We used the maximum-likelihood-
method (MLM) to estimate our confirmatory model since this estimator is robust to 
standard errors and is one of the most common estimators (38). Goodness of fit was 
measured with chi-square significance test, comparative fit index (CFI) (39) and root 
mean square error of approximation (RMSEA) (40). To analyze the association of FTD 
dimensions and brain structure we extracted latent standardized factor scores for each 




MRI data acquisition  
T1 weighted images and diffusion weighted images were obtained using a 3 T 
MRI scanner (Münster: Prisma, Siemens, Erlangen, Germany; Marburg: Tim Trio, 
Siemens, Erlangen, Germany). In Münster, a 20 channel head matrix Rx-coil was used. 
MRI data in Marburg were obtained in cooperation with the Core-Unit Brainimaging, 
Faculty of Medicine, University of Marburg, Germany using a 12 channel head matrix 
Rx-coil. MRI data was acquired according to an extensive quality assurance protocol 
(41).  
T1 weighted images were acquired using a fast gradient echo MP-RAGE 
sequence with a slice thickness of 1.0 mm consisting of 176 sagittal orientated slices in 
Marburg and 192 slices in Münster and a FOV of 256mm and the following parameters 
at the two sites: Marburg: TR=1.9s, TE=2.26ms, TI=900ms, flip angle=9°; Münster: 
TR=2.13s, TE=2.28ms, TI=900ms, flip angle=8°.  
DTI scans were acquired using an epi2d sequence (TR 7300ms, TE 90ms, FOV 
320mm, phase encoding anterior-posterior, 56 slices with 2.5 mm slice thickness in 
Münster, 3mm thickness in Marburg) with a final voxel resolution of 2.5 x 2.5 x 2.5 mm3. 
For all patients, two sets of 30 diffusion-weighted images (b=1000s/mm2) and four non-
diffusion weighted images (b=0s/mm2) were acquired. MRI data acquisition and the 
assessment of FTD symptoms were performed within the same week. 
 
Pre-processing 
For T1 weighted images, we used the default parameters as implemented in the 
CAT12 toolbox (Computation Anatomy Toolbox for SPM, build 1184, Christian Gaser, 
Structural Brain Mapping group, Jena University Hospital, Germany) 
(http://dbm.neuro.uni-jena.de/cat/) building on SPM12 (Statistical Parametric Mapping, 
Institute of Neurology, London, UK). During pre-processing, images were spatially 
registered, segmented (42,43) and normalized (44). T1-MRI data sets were spatially 
smoothed with a Gaussian kernel of 8 mm FWHM. Total intracranial volume (TIV) was 
calculated during pre-processing.  
 Before pre-processing, all DTI scans were visually inspected for major artifacts 
or caliber gaps. For DTI analyses, we used a tract-based spatial statistics (TBSS) 
approach running under FSL (version 6.0; the Oxford Centre Functional Magnetic 
Imaging Software Library; Oxford, UK (45)). Data were pre-processed using default 
parameters. During pre-processing, data were corrected for motion and Eddy-Current 
artefacts (46). Images were non-linearly registered into standard Montreal Neurological 
Institute (MNI) space (47) using a FSL template. Fractional anisotropy (FA) maps were 
projected on mean skeletons with a 0.2 threshold to prevent alignment errors. 
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Voxel-based morphometry and diffusion-tensor-imaging statistical analyses  
All brain structural analyses were performed using separate linear regression 
analyses for each factor. Several covariates of no interest were included in both analyses 
(age, sex, site and TIV, and the change of a gradient coil) (30,41). To consider potential 
medication effects, three dummy coded covariates accounting for the intake of 
antidepressants, mood stabilizers and antipsychotics were used. 
VBM analyses were performed using SPM12 (v6906) 
(https://www.fil.ion.ucl.ac.uk/spm/). As recommended for VBM analyses, absolute 
threshold masking with a threshold value of 0.1 was used (http://dbm.neuro.uni-
jena.de/cat/). Results were considered significant at p<.05 cluster-level family wise error-
corrected (FWE) for multiple comparisons after an initial threshold of p<.001 uncorrected, 
and a k>10 threshold. Cluster labeling was applied using the Dartel space 
Neuromorphometrics atlas (http://www.neuromorphometrics.com/).  
Tract-based, voxel-wise DTI analyses were performed using threshold-free 
cluster enhancement (TFCE). We performed 5000 permutations for GLM contrast 
generation (48). The JHU DTI 81 white-matter labels atlas and the JHU white-matter-
tractography atlas (49) were used for cluster labelling. MNI coordinates were retrieved 
with the cluster tool of FSL. Results were considered significant at p<.05 FWE-corrected 
(peak-level), and threshold k>10.  
ANCOVA interaction analyses for each factor with DSM-IV diagnostic categories 
were performed in SPM and FSL (factor x diagnosis, full-factorial model), to test whether 
transdiagnostic brain correlates of FTD dimensions were driven by DSM-IV diagnostic 
categories. Adding DSM-IV diagnostic categories as covariates to the multiple 
regression analyses would have contradicted our approach as diagnoses somehow rest 
on symptoms, therefore interaction analyses were performed for both the GMV and DTI 
analyses. 
Since DSM-IV categories were unequally distributed, we again performed 
multiple regression analyses as described above in a sub-sample with equal patient 
numbers for each of the three diagnoses (n=351 for the VBM sample and n=309 for the 
DTI sample). Therefore, we used significant clusters from the total sample analyses as 
ROIs for the analyses in the matched sample. Again, ANCOVA interaction analyses in 
SPM and FSL were performed in the matched sample. 
To better understand brain structural mechanisms across white and gray matter, 
we tested whether the VBM and DTI clusters correlating with one of the 
psychopathological factors were associated, using partial correlations including the 
covariates from brain structural analysis. Eigenvariate values approximating mean 




Exploratory psychopathology factor analysis of sub-sample 1 
After varimax rotation and the suggestion of the ScreePlot (eFigure1), the 
principal axis factor analysis revealed a 3-factor structure (Table 2). Symptoms 
summarized in less than three factors did not make sense clinically and were superficial. 
In factor models with more than three factors (i.e. four factors) the last factor comprised 
only one symptom (SAPS32: distractibility). Factors only including one item cannot be 
considered as a symptom dimension. The 3-factor model included the following factors 
(explaining 50.58% of variance): verbosity (=.857; 21.76 % of variance), emptiness 
(=.757; 15.23% of variance), and disorganization (=.728; (13.58% of variance).  
 
Table 2: Explorative psychopathological FTD factors of sample 1 (n=537) 




SAPS 27 tangentiality 0.926 0.857 
SAPS 26 derailment 0.734 
 
SAPS 30 circumstantiality 0.695 
 





SANS 8 poverty of speech 0.755 0.757 
SANS 9 poverty of content 0.698 
 




SANS 10 blocking 0.545 
 
disorganization 
SAPS 28 incoherence 0.874 0.728 
SAPS 29 illogicality 0.590 
 
SAPS 32 distractibility 0.527 
 
 
Confirmatory psychopathology factor analysis of sub-sample 2 
To cross-validate our explorative factor model, we performed a confirmatory 
factor analysis using the second sample (n=534). We confirmed the 3-factor model. Fit 
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indices of the second sample showed an acceptable fit: 2=44.88, df=21, p<.0001, 
CFI=0.909, RMSEA=0.046. To test whether our model fit the whole sample, we 
performed a confirmatory factor analysis in the whole sample (N=1,071) also showing a 
good fit 2=66.097, df=21, p<.0001, CFI=0.928, RMSEA=0.045. We were able to 
replicate the explorative model in the age- and sex-matched sample, too, presented in 
eResults 1 (supplement).  
 
Association of FTD psychopathology factors with gray matter volume  
In a next step, we investigated the association of each FTD factor and GMV in 
the whole sample (N=1,071), using latent standardized factor scores for each patient and 
factor in multiple regression models. Verbosity correlated negatively with a cluster 
including the left (L) middle occipital gyrus (MOG) (63%), L inferior occipital gyrus (29%), 
and the L angular gyrus (7%) (k=872, x/y/z=-40.5/-66/12, t=4.7, p=.035 FWE cluster-
level corrected) (see Figure 1A). Emptiness showed a negative correlation with a cluster 
comprising the L hippocampus (41%), L cerebral white matter (36%), L thalamus proper 
(7%), L parahippocampal gyrus (7%), and the L posterior cingulate gyrus (5%) (k=842, 
x/y/z=-31.5/-25.5/-15, t= 4.19, p=.039 FWE cluster-level corrected) (see Figure 1B). 
There was no FWE cluster-level corrected association for the disorganization factor. Full-
factorial interaction analyses in SPM (DSM-IV diagnostic category x FTD factor) were 
performed to test if local GMV associations with FTD dimensions were driven by DSM-
IV diagnoses. There was no interaction effect at the suggested threshold (p<0.05 cluster-
level FWE-corrected) in the total sample (N=1,071).  
To further test if GMV associations were driven by DSM-IV diagnoses, we 
performed regression analyses again in an age- and sex matched sample which included 
the same number of patients from each of the three diagnostic categories (n=351). 
Significant clusters from the whole brain analysis in total sample could be replicated in 
the diagnostically matched sample (see eResults2). Comparable to the total sample, 
there was no interaction with DSM-IV diagnoses for both the verbosity and the emptiness 
factor on GMV in the diagnostically matched sample, either.  
 
Association of FTD factors and FA 
We tested the relationship of FTD factors and the microstructure of white matter (FA) 
DTI tracts using multiple regression analyses for each factor in the whole sample (n=830) 
(see Figure 2A and B). FWE peak-level corrected results are presented in Table 3. 
Verbosity and disorganization were differentially associated with white matter FA, 
including positive associations of verbosity with the R ILF and posterior cingulum bundle. 
Disorganization was correlated negatively with the bilateral ATR and positively with the 
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hippocampal part of the cingulum bundle. There was no FWE peak-level association for 
the emptiness factor. We were able to retrieve significant clusters of the total sample in 
the age- and sex-matched sample (same n per diagnosis), too (see supplement 
eTable6). Comparable to GMV analyses, we performed interactions analyses (DSM-IV 
diagnoses x FTD factor) in FSL to test if local white matter associations were driven by 
DSM-IV diagnoses. There was no interaction effect in the total and in the diagnostically 
matched sample.  
 
Table 3: Association of formal thought disorder factors and fractional anisotropy diffusion 





































R 24 .028 












Figure 1 A and B: Association of formal thought disorder dimensions and gray matter 
volume in patients with major depressive disorder, bipolar disorder, and schizophrenia 
spectrum disorder (N=1,071). Clusters of significant negative (blue) correlations at p < 




Figure 2 A and B: Association of formal thought disorder dimensions and fractional 
anisotropy in the whole DTI sample (n=830). Clusters of significant positive (red) and 
negative (blue) correlations at p<.05, peak-level family-wise-error-corrected. The 





Association of significant GMV and DTI clusters 
As we detected alterations in both brain modalities (gray and white matter) for the 
verbosity factor, we investigated the correlation between these results to better 
understand brain structural mechanisms. Therefore, we used partial correlation analyses 
for the verbosity FTD dimension in the whole sample and correlated GMV clusters with 




We investigated the association of FTD psychopathological dimensions with 
white and gray matter in a large transdiagnostic cohort of patients with MDD, BD and 
SSD. Our study revealed an exploratory and confirmatory psychopathological three 
factor model across disorders comprising verbosity, disorganization and emptiness FTD 
dimensions. The verbosity dimension was negatively associated with a GMV cluster 
comprising parts of the temporo-occipital language junction including the L MOG and 
angular gyrus. Furthermore, we found a positive fiber tract association of the verbosity 
factor with the R posterior CB and the R IFL. The disorganization FTD factor was 
negatively associated with the bilateral ATR, and positively with the R 
cingulum/hippocampus bundle. The emptiness dimension was negatively associated 
with a GMV cluster comprising the L hippocampus and thalamus. Importantly, all VBM 
and DTI – FTD psychopathology factor associations were independent of DSM-IV 
diagnoses. This points to a shared relationship between FTD dimensions and brain 
structure across diagnoses. Furthermore, there was no correlation between VBM and 
DTI clusters of the verbosity factor indicating one given FTD syndrome/dimension can 
arise from different brain structural changes, a result well known e.g. from aphasia 
research. 
Previous studies using the SAPS and SANS that only included patients with SZ, 
showed a three factor model encompassing emptiness (poverty/nFTD), verbosity, and 
disorganization (9). Unlike previous studies focusing only on SZ patients (1,8,9), we 
extend existing psychopathological factor models of FTD across psychotic and affective 
disorders using a cross-validated model. Our results demonstrate that FTD encompass 
three independent dimensions across categorical disorders.  
Moreover, our study provides first large-scale evidence that FTD dimensions are 
differentially correlated with gray and white matter anatomical structures across 
diagnoses. The verbosity factor was negatively associated with a GMV cluster in the L 
temporo-occipital language junction comprising parts of the angular and middle occipital 
gyri. The L angular gyrus is part of the Wernicke speech area which has been associated 
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with the total severity of FTD symptoms in SZ patients (50), corroborating our results. 
Moreover, the L MOG has been linked to semantic paraphasia and neologisms during 
free speech production in aphasia patients (51) pointing to derailed speech which 
coincides with the verbosity dimension across psychiatric patients in the present study. 
In aphasia patients, the L MOG has been associated with semantic errors in naming 
tasks (52,53). In our study, verbosity was further positively correlated with FA of two 
white matter tracts: the R ILF and the R posterior CB. Previously, the ILF has been 
associated with verbosity in SZ patients (22). It indirectly connects posterior temporal 
and occipital areas and the frontal lobe (54). Together with other ventral white matter 
tracts, the ILF forms part of the semantic ventral stream (55), which is, e.g. implicated in 
linking objects to the appropriate lexical meaning (56) and more generally to lexical 
access. The right lateralization might indicate a reversed lateralization in patients which 
has also been observed during fMRI speech production tasks in SZ (57). These 
associations might indicate a global brain structural dysconnectivity which has already 
been reported in SZ patients (19), being generally implicated in FTD (20,58).  
The factor disorganization was correlated with white matter tracts in the bilateral 
ATR and the R cingulum-hippocampus bundle. The ATR connects the dorsolateral 
prefrontal cortex with the thalamus (59). Altered FA in the ATR has been reported in BD 
(59) and SZ (60) patients. Our results further coincide with a previous SZ study (22) 
showing bilateral associations of the ATR with a global FTD language score. Further 
evidence is given by lesion studies in aphasia patients (24) indicating that the reduced 
FA of the ATR is associated with impairments in verbal fluency tasks. There was no 
association of the disorganization factor and GMV indicating differential brain structural 
mechanisms being involved in different FTD domains. 
The emptiness factor in our study was negatively associated with a GMV cluster 
comprising parts of the L hippocampus, thalamus, and posterior cingulate gyrus. This 
result is in line with previous studies in SZ patients (15,16,18). Additionally, functional 
imaging studies in SZ indicated that impaired free word generation is mediated by the 
hippocampus (61,62). No correlations to white matter FA were present. 
In summary, the brain structural correlates of our psychopathological FTD factors 
in MDD, BD and SSD have previously been implicated with speech pathology in aphasia 
and SZ patients. This corroborates our results and opens a new road to 
psychopathological syndrome -and not diagnosis - based etiological and pathogenic 







Some limitations should be considered. First, the MDD group was the largest in 
our transdiagnostic sample which might have biased our results. However, interaction 
analyses in both the whole and the diagnostically matched sample revealed no 
interaction of DSM-IV diagnostic categories and FTD factors on local brain structural 
correlates. Second, the SANS and SAPS are designed to measure a broad variety of 
symptoms, rather than specifically FTD (2,63). Using more detailed scales collecting 
even more FTD symptoms might result in a higher number of extracted factors and 
subsequently in differential brain structural correlates of FTD. Nevertheless, SANS and 
SAPS are two economical and well-validated scales that have been widely used in FTD 
research. Third, factor dimensions were based on current FTD symptoms and statistical 
models did not include remission of patients. Correlating current state measures with 
brain structure might lead to volatile results (64). Nevertheless, acute syndromes may 
be an indication for a particular neuroanatomical, state independent alteration that 
outlasts current symptoms. The investigation of the stability of FTD factors across time 
and their association to brain structure would be of great interest.  
 
Conclusion 
Together, our results provide first evidence of common neurobiological structures 
involved in FTD across affective and psychotic disorders. Since the anatomical 
correlates of white and gray matter did not correlate with each other, we speculate that 
firstly, the same psychopathological symptoms can result from changes in different 
neuroanatomical substrates, a fact known from aphasia research, which might explain in 
part the heterogeneous findings of FTD neural correlates in SZ. Secondly, these different 
neuroanatomical correlates might be due to a diverse range of environmental and 
genetic factors (and their interactions) impacting at different time points in the developing 
brain. Consequently, different etiologies may result in a range of diverse brain changes, 
nevertheless giving rise to a homogeneous syndrome, e.g. disorganization or verbosity. 
Dimensional approaches as applied in this present study are a key in overcoming a 
scientific deadlock in neurobiological research disentangling the dimensional variety of 
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eResults1: Confirmatory factor analysis of the age- and sex-matched sample  
To test whether results were driven by unequal sample sizes of each DSM-IV 
diagnostic category we performed factor and brain structural analyses again in an age- 
and sex-matched sample. The matched VBM sample included n=351 patients (MDD 
n=117, BD n=117, SSD n=117). Confirmatory factor analyses of the matched VBM 
sample showed a good fit: 2=51.43, df=20, p=.0001, CFI=0.924, RMSEA=0.045. The 
matched DTI sample included n=309 patients (MDD n=103, BD n=103, SSD n=103). 
Confirmatory factor analyses of the matched DTI sample also showed a good fit: 
2=44.88, df=20, p=.0011, CFI=0.926, RMSEA=0.039.  
 
eResults 2: Associations of FTD factors and brain structure in the age- and sex-matched 
sample 
To rule out potential effects caused by the unequal distribution of DSM-IV 
diagnostic categories we performed regression analyses again in an age- and sex-
matched VBM sample (n=351). Therefore, significant clusters of the total sample were 
used as ROIs. We were able to replicate results of the total sample in the matched 
sample, too (F1, L MOG cluster: k=95, x/y/z=-39/-68/12, p=.011, FWE cluster-level 
corrected; F2 L hippocampus cluster: k=23, x/y/z=-21/-42/-2, p=.024 FWE cluster-level 
corrected). DTI results are presented in eTable6. For both GMV and FA clusters no 
interaction (analyses performed in SPM/FSL) of factor x DSM IV diagnostic categories 







































13.25 (2.7) 14.06 (2.79) 12.54 (2.54) .008b  
SANS alogia 
subscale 
0.53 (1.47) 0.52 (1.16) 2.24 (2.98) <.001c  
SAPS pFTD 
subscale 
0.29 (1.23) 2.19 (3.55) 3.49 (4.4) <0.001d  
SANS sum 7.84 (9.31) 5.6 (7.38) 14.36 (14.62) <.001c 
SAPS sum 0.58 (1.87) 2.96 (4.81) 11.17 (13.36) <.001d 
YMRS sum 1.44 (1.85) 4.85 (6.44) 3.08 (5.31) <.001d 
HAM-D sum 8.37 (6.47) 6.36 (5.97) 6.97 (6.14) .003e 
Mean (standard deviation); TIV (= total intracranial volume); SANS (= scale for the 
assessment of negative symptoms (31)); SAPS (= scale for the assessment of positive 
symptoms (32)); YMRS (= Young mania rating scale (33)); HAM-D (=Hamilton rating 




c MDD<SSD; BD<SSD 
d MDD<BD,SSD; BD<SSD 
e BD<MDD  
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13.18 (2.77) 14.06 (2.78) 12.5 (2.84) .009b  
SANS alogia 
subscale 
0.46 (1.13) 0.73 (1.56) 1.41 (2.19) <.001c  
SAPS pFTD 
subscale 
0.42 (1.54) 1.23 (2.76) 2.76 (4.54) <.001d  
SANS sum 7.11 (7.92) 5.88 (7.32) 12.78 (9.75) <.001c 
SAPS sum 0.75 (2.28) 1.77 (3.65) 8.9 (11.64) <.001c 
YMRS sum 1.42 (2.33) 2.91 (5.22) 2.29 (5.54) .001a 
HAM-D sum 8.39 (6.33) 7.21 (5.69) 6.52 (5.545) .049e 
Mean (standard deviation); TIV (= total intracranial volume); SANS (= scale for the 
assessment of negative symptoms (31)); SAPS (= scale for the assessment of positive 
symptoms (32)); YMRS (= Young mania rating scale (33)); HAM-D (=Hamilton rating 
scale for depression (34)). Tukey´s post hoc test was performed to investigate group 
differences. 
a MDD<BD 
b MDD<BD; SSD<BD 
c MDD<SSD; BD<SSD 
































13.13 (2.77) 14.31 (2.84) 12.68 (2.77) 




0.54 (1.38) 0.58 (1.34) 1.68 (2.46) <.001b  
SAPS pFTD 
subscale 
0.4 (1.47) 1.63 (3.04) 3.15 (4.6) <.001c  
SANS sum 7.71 (8.84) 5.55 (7.28) 12.71 (10.74) 
<.001d 
 
SAPS sum 0.73 (2.15) 2.18 (3.77) 9.63 (12.28) 
<.001c 
 
YMRS sum 1.37 (2.09) 3.21 (5.1) 2.68 (5.04) 
<.001e 
 
HAM-D sum 8.38 (6.57) 6.48 (6.01) 6.33 (5.27) 
<.001f 
 
Mean (standard deviation); TIV (= total intracranial volume); SANS (= scale for the 
assessment of negative symptoms (31)); SAPS (= scale for the assessment of positive 
symptoms (32)); YMRS (= Young mania rating scale (33)); HAM-D (=Hamilton rating 
scale for depression (34)). Tukey´s post hoc test was performed to investigate group 
differences. 
a MDD<BD; SSD<BD 
b MDD<SSD; BD<SSD 
c MDD<BD,SSD; BD<SSD 
d MDD<SSD; BD<SSD 
e MDD<SSD, BD 
f BD<MDD; SSD<MDD  
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eTable 4: Descriptive statistics of the VBM subsample with the same n for each of the 













age 38.21 (11.71) 39.74 (11.62) 38.23 (11.71) 
.407 
 














13.2 (2.75) 14.23 (2.78) 12.52 (2.67) <.001a  
SANS alogia 
subscale 
0.5 (1.1) 0.56 (1.32) 1.83 (2.64) <.001b  
SAPS pFTD 
subscale 
0.4 (1.31) 1.85 (3.35) 3.13 (4.47) <.001c  
SANS sum 7.7 (7.83) 5.48 (7.15) 13.57 (12.4) 
<.001b 
 
SAPS sum 0.6 (1.51) 2.6 (4.49) 10.03 (12.52) 
<.001b 
 
YMRS sum 1.35 (2.21) 3.85 (5.92) 2.69 (4.94) 
<.001d 
 
HAM-D sum 9.13 (6.86) 6.54 (5.92) 6.74 (5.79) 
.005e 
 
Mean (standard deviation); TIV (= total intracranial volume); SANS (= scale for the 
assessment of negative symptoms (31)); SAPS (= scale for the assessment of positive 
symptoms (32)); YMRS (= Young mania rating scale (33)); HAM-D (=Hamilton rating 
scale for depression (34)). Tukey´s post hoc test was performed to investigate group 
differences. 
a MDD<BD; SSD<BD 
b MDD<SSD; BD<SSD 
c MDD<SSD, BD; BD<SSD 
d MDD<BD 




eTable 5: Descriptive statistics of the DTI subsample with the same n for each of the 













age 38.06 (11.65) 40.27 (11.83) 38.79 (11.59) 
.295  
 














13.37 (2.75) 14.31 (2.84) 12.68 (2.77) <.001a  
SANS alogia 
subscale 
0.39 (0.94) 0.58 (1.34) 1.68 (2.46) <.001b  
SAPS pFTD 
subscale 
0.3 (0.88) 1.63 (3.04) 3.15 (4.6) <.001c  
SANS sum 7.49 (7.58) 5.55 (7.28) 12.71 (10.74) 
<.001b 
 
SAPS sum 0.53 (1.2) 2.18 (3.77) 9.63 (12.28) 
<.001b 
 
YMRS sum 1.35 (2.06) 3.21 (5.1) 2.68 (5.04) 
<.001d 
 
HAM-D sum 9.11 (7.08) 6.48 (6.01) 6.33 (5.27) 
<.001e 
 
Mean (standard deviation); TIV (= total intracranial volume); SANS (= scale for the 
assessment of negative symptoms (31)); SAPS (= scale for the assessment of positive 
symptoms (32)); YMRS (= Young mania rating scale (33)); HAM-D (=Hamilton rating 
scale for depression (34)). Tukey´s post hoc test was performed to investigate group 
differences. 
a SSD<BD 
b MDD<SSD; BD<SSD 
c MDD<SSD, BD; BD<SSD 
d MDD<BD  
e BD<MDD; SSD<MDD  
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eTable 6: Association of FTD factors and DTI tracts in the subsample with the same n 










































eFigure1: Screeplot of the exploratory factor analysis in psychopathological sub-







eFigure2: Post hoc visualization of the interaction analyses of the left middle occipital 
gyrus cluster and factor 1 “verbosity”. No interaction of categorical diagnosis and factor 














eFigure3: Post hoc visualization of the interaction analyses of the right inferior 
longitudinal fascicle FA and factor 1 “verbosity”. No interaction of categorical diagnosis 















eFigure4: Post hoc visualization of the interaction analyses of the right cingulum bundle 















eFigure5: Post hoc visualization of the interaction analyses of the left hippocampal 















eFigure6: Post hoc visualization of the interaction analyses of the left anterior thalamic 
radiation FA and factor 3 “disorganization”. No interaction of categorical diagnosis and 














eFigure7: Post hoc visualization of the interaction analyses of the right anterior thalamic 
radiation FA and factor 3 “disorganization”. No interaction of categorical diagnosis and 














eFigure8: Post hoc visualization of the interaction analyses of hippocampal part of the 
right cingulum bundle FA and factor 3 “disorganization”. No interaction of categorical 
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